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Abstract 
Supply chain management (SCM) practitioners who ship temperature-sensitive diagnostic 
medical devices (DMDs) to clinicians must use effective cold chain management (CCM) 
strategies to avoid temperature excursions that contribute to medical device errors.  Such 
errors have caused patient harm and death, which costs the U.S. health care system 
billions of dollars per year.  The purpose of this qualitative multiple case study was to 
explore strategies for selecting and managing cold chain shipping solutions (CCSSs) 
requiring SCM executives to trade cost for regulatory compliance and predictability when 
mitigating temperature variations that occur during shipping.  The conceptual framework 
for the study was the 6-change approaches, and its underpinnings that framed the 
exploration into the strategies some medical device executives use for shipping 
temperature-sensitive DMD tests and controls.  Data were collected from in-depth 
interviews, field notes, and existing literature.  The target population was 3 SCM 
executives working in California, New Jersey, and Ireland with at least 5 years of CCM 
experience in the medical device industry.  A purposive sampling procedure guided the 
selection of participants for in-depth interviews.  The data analysis included pattern 
matching techniques, central analysis, and collapse analysis.  The results of this study 
indicated 3 successful strategies: validation of CCSSs, compliant shipping of DMDs, and 
CCM best practices.  The study was socially significant because the findings may prevent 
medical device failures that have caused U.S. Food and Drug Administration recalls and 
patient harm.
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Section 1: Foundation of the Study  
Supply chain management (SCM) practitioners use cold chain shipping solutions 
(CCSSs) to distribute temperature-sensitive diagnostic medical device (DMD) tests and 
controls to clinicians who work in hospitals and doctor offices.  Clinicians use DMD tests 
and controls to diagnose various diseases, such as cardiovascular, respiratory, toxicology, 
autoimmune, and infectious diseases presented in patients.  Some of these DMD tests and 
controls contain monoclonal antibody technology, reagents, antigens, serums, and other 
biological compounds, many of which are temperature sensitive.  The temperature 
requirements for some DMD tests and controls can range from 2 to 8, –20, and –80 °C, as 
well as ambient or control room temperature.  The temperature sensitivity of DMD tests 
and controls requires SCM executives to implement consistent cold chain management 
(CCM) strategies and execute these strategies throughout the global supply chain.  To 
achieve this objective, SCM executives working in the medical device industry should 
collaborate to align U.S. and international CCM strategies.  The global alignment of 
CCM strategies may increase the probability of SCM practitioners using validated CCSSs 
for the distribution of temperature-sensitive DMD tests and controls.  The objective of 
this doctoral study was to explore the strategies used by SCM executives in the selection 
of CCSSs in the medical device industry. 
Background of the Problem 
Agents for the U.S. Food and Drug Administration (FDA) are responsible for 
regulating the medical device industry in the United States.  These agents use premarket 
approval (PMA) and the 510(k) clearance process to regulate the medical device industry 
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(Kramer, Xu, & Kesselheim, 2012a).  Agents also employ the PMA and 510(k) clearance 
process to ensure medical device manufacturers are compliant with temperature storage 
and distribution (FDA, 2011).  The temperature requirements for the storage and 
distribution of DMDs originate from the stability studies conducted by scientists 
(Schofield, 2009).  Consequently, agents for the FDA require medical device 
manufacturers to have compliant product labeling for temperature storage and 
distribution (FDA, 2011). 
Problem Statement 
Clinicians using defective DMDs contribute to medical errors, a leading cause of 
injury and death that cost the U.S. health care system approximately $17.1 billion in 2008 
(Van Den Bos et al., 2011).  Agents for the FDA recorded 659 instances of medical 
device recalls in 2006, which contributed to 116,086 injuries and 2,830 deaths (FDA, 
2006; Sullivan, 2014).  Medical device recalls increased 80.6% from 2006 through 2012 
(Sullivan, 2014).  Proper CCM can prevent some medical errors by protecting proteins, 
antigens, and assays used in DMD tests and controls from temperature excursions 
(O’Connell et al., 2012; Smit et al., 2013).  The general business problem was executives 
lack CCM standardization in distributing DMDs in the medical device industry.  The 
specific business problem was some medical device executives lack strategies for 
shipping temperature-sensitive DMD tests and controls. 
Purpose Statement 
The purpose of this qualitative multiple case study was to explore medical device 
executives’ strategies for shipping temperature-sensitive DMD tests and controls.  The 
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target population consisted of three SCM executives working in the medical device 
industry.  The geographic locations for participants were California, New Jersey, and 
Ireland. 
Insight into the diversification or lack of standardization of CCSSs used by SCM 
executives in the medical device industry may contribute to CCM strategies, new 
knowledge, increased quality, and financial savings.  The identification of CCM 
strategies could fast-track SCM executives’ adoption of CCSSs that mitigate DMD 
temperature excursions and associated medical errors.  SCM executives who adopt CCM 
strategies could advance social and economic benefits on a global scale by reducing the 
medical errors that cause patient harm and death. 
Nature of the Study 
I used the qualitative research methodology to guide this study because little was 
known about the phenomenon and the industry niche, and there was a lack of structured 
archival and survey data.  Quantitative methodology is to measure variables through 
statistical analysis, which made this research method inappropriate for this exploratory 
study (see Brédart, Marrel, Abetz-Webb, Lasch, & Acquadro, 2014; Yilmaz, 2013).  
Mixed-methods research includes quantitative and qualitative approaches, which made 
the mixed-methods approach inappropriate.  Terrell (2012) confirmed that researchers 
use qualitative methods to explore how and why a phenomenon occurs or occurred.  
Qualitative methodology was appropriate for exploring an under-researched phenomenon 
in a niche industry. 
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I considered narrative, phenomenological, ethnographic, and case study designs.  I 
constrained the research design choice by using cognitive mapping as my primary 
technique in exploring the phenomenon.  The use of cognitive mapping narrowed the 
design option to phenomenological and case study.  Next, I considered that researchers 
use the phenomenological design to analyze interview data and draw conclusions based 
on participants’ lived experiences (Ackermann, Eden, & Cropper, 1992).  After ruling out 
the phenomenological design, I chose a case study design to support the qualitative nature 
of my research question and the real-time cognitive mapping of participants.  The case 
study design is an excellent framework to explore health and social science phenomena to 
understand the shared practical experiences of participants (Baxter & Jack, 2008; Halkier, 
2013; Wolgemuth et al., 2014).  The application of cognitive mapping across individual 
participants helped me to generalize the strategies across all participants. 
Research Question 
I applied a qualitative multiple case study design with cognitive mapping to 
explore strategies SCM executives deploy in the selection, management, and utilization 
of CCSSs in the medical device industry.  The research question should dictate the 
research method and design (Kaczynski, Salmona, & Smith, 2014).  The following 
overarching research question directed this study: What are the strategies some medical 
device executives use for shipping temperature-sensitive diagnostic medical device tests 
and controls? 
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Interview Questions 
I constructed cognitive maps through in-depth and prolonged interviews with 
informants to discover new facts and personal insights into the phenomenon.  Prolonged 
interviews can take researchers 2 hours to complete (Yin, 2014).  The case study design 
is appropriate for asking how and why interview questions, which is fitting for cognitive 
mapping (Yin, 2014).  Prolonged case study interviews use propositions and 
semistructured interview questions that are open-ended to achieve a conversational tone 
with informants (Yin, 2014).  By definition, a proposition is a statement or assertion that 
expresses judgment or opinion and is synonymous with hypothesis, theory, premise, and 
construct (“Proposition,” n.d.).  A prolonged interview requires the use of propositions, 
which guide an interviewer by encouraging him or her to ask spontaneous follow-up 
questions that align with the study (Yin, 2014).  Baxter and Jack (2008) indicated that 
propositions provide focus and structure in answering the overarching research question. 
I developed three propositions and constructed how and why interview questions 
to guide this case study.  Proposition 1 was that CCSSs used in the medical device 
industry are validated, nonvalidated, or poorly validated.  This use may indicate a lack of 
standardization and inconsistent distribution strategies.  Proposition 2 was that 
organizational and educational requirements for SCM executives in the medical device 
industry might be inconsistent, which leads to the use of nonvalidated or poorly validated 
CCSSs.  Proposition 3 was that SCM executives in the medical device industry have 
varying competency regarding the distribution requirements for DMD tests and controls 
from a regulatory and stability perspective, which may contribute to inconsistent industry 
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standards and health risks to patients.  I then created and categorized how and why 
interview questions based on the three propositions, as shown in Table 1. 
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Table 1 
Creation and Categorization of Interview Questions Based on Propositions 
Propositions Interview questions 
P1. Cold chain shipping 
solutions (CCSSs) used in 
the medical device 
industry are validated, nor 
validated, or poorly 
validated, which may 
indicate a lack of 
standardization and 
inconsistent distribution 
strategies. 
Q1. What types of CCSSs do you deploy in your 
supply chain? 
Q2. What methods do you use to evaluate CCSSs 
intended to protect against extreme temperature 
ranges? 
Q3. How do you monitor the effectiveness of CCSSs 
used to ship diagnostic medical device (DMD) 
tests and controls? 
Q4. How do you validate CCSSs used in your supply 
chain? 
Q5. What cold chain shipping innovations are you 
considering for your organization? 
 
P2. Organizational and 
educational requirements 
for supply chain 
management (SCM) 
executives in the medical 
device industry may be 
inconsistent, which leads 
to the use of nonvalidated 
or poorly validated 
CCSSs. 
 
Q6. How did you learn about cold chain management 
(CCM) as it pertains to the medical device 
industry? 
Q7. How do you identify CCM deficiencies within 
your organization? 
Q8. How does education influence your selection of 
CCSSs for DMD tests and controls? 
Q9. How do you increase CCM awareness within 
your organization? 
Q10. How do you develop CCM expertise within your 
organization? 
 
P3. SCM executives in the 
medical device industry 
have varying competency 
regarding the distribution 
requirements for DMD 
tests and controls from a 
regulatory and stability 
perspective, which may 
contribute to inconsistent 
industry standards and 
health risks to patients. 
Q11. How do you determine the need for temperature-
controlled shipping? 
Q12. How does the FDA influence the shipping of 
DMD tests and controls? 
Q13. How do you ensure internal CCM compliance 
when shipping? 
Q14. How does temperature excursion on DMD tests 
and controls affect patient safety? 
Q15. Why do you ensure temperature-compliant 
shipping for DMD tests and controls? 
Q16. How do governmental regulations influence the 
CCM of DMD tests and controls? 
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Conceptual Framework 
I used Kotter and Schlesinger’s (1979) six-change approaches (SCA) model as the 
conceptual framework for this study.  The premise for the SCA model is that leaders who 
seek sustainable change must select strategies that diminish the resistance to change, 
which is inherent in people who do not want internal and or external forces that disrupt 
the status quo (Kotter & Schlesinger, 1979).  Propositions that supported the selection of 
the SCA model were (a) education and communication, (b) participation and 
involvement, (c) facilitation and support, (d) negotiation and agreement, (e) manipulation 
and cooptation, and (f) explicit and implicit coercion (see Kotter & Schlesinger, 1979). 
I used the SCA model to construct propositions and interview questions grounded 
in the conceptual framework for the study.  Leaders can use the propositions in the SCA 
model as strategies to prevent or decrease an individual or group’s resistance to change 
(Kotter & Schlesinger, 1979).  As applied in this study, the SCA model included 
organizational change management strategies that SCM executives can use to standardize 
the CCSSs for shipping temperature-sensitive DMD tests and controls. 
Operational Definitions 
510(k): 510(k) is a clearance process used by FDA agents for ensuring the safety 
and effectiveness of medical devices entering the market that are equivalent to existing 
medical device technology (Kramer et al., 2012a). 
Cold chain management (CCM): CCM is the process of ensuring temperature 
control of perishable and temperature-sensitive goods, from storage through distribution, 
in active or passive CCSSs (White & Cheong, 2012). 
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Cold chain shipping solutions (CCSSs): CCSSs are containers that maintain the 
required temperature of goods during transit (Lis, Gourley, Wilson, & Page, 2009). 
Premarket approval (PMA): PMA is a clearance process used by FDA agents 
during the premarket review to ensure high-risk medical devices pass clinical trials 
without adverse events (Kramer et al., 2012a). 
Stability study: A stability study is a regulatory licensure requirement to 
determine product shelf life through a study of the effects of temperature on products 
during the storage and shipping of products and use conditions of those products for 
consumers (Schofield, 2009). 
Temperature excursion: A temperature excursion occurs when a product 
encounters an undesirable temperature during transit because of cold storage failure and 
mishandling (Schofield, 2009). 
Assumptions, Limitations, and Delimitations 
This qualitative multiple case study included assumptions, limitations, and 
delimitations.  The assumptions, limitations, and delimitations presumed facts, and 
unintentional and intentional boundaries associated with this study. 
Assumptions 
A number of key assumptions were required to conduct this doctoral study.  
Dusick (2015) defined assumptions as unverifiable assertions claimed by a researcher in 
conducting his or her study.  The assumptions for this study involved the phenomenon 
under investigation and the participants. 
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I made the following assumptions based on the phenomenon under investigation.  
DMD tests and controls have specific temperature requirements for storage and 
distribution.  The improper storage and distribution of DMD tests and controls may 
adversely affect patient safety.  The risk to patient safety could provide a rationale as to 
why SCM executives use CCSSs to maintain specific temperature ranges for DMDs 
during transit. 
I made the following assumptions based on participant participation in this 
qualitative multiple case study.  Purposive sampling of participants resulted in voluntary 
participants.  I assumed that SCM executives who participated in the study were 
knowledgeable and truthful in their interview responses.  I also assumed that SCM 
executives had CCM responsibilities in their respective companies in the medical device 
industry, and that the participants were familiar with the phenomenon under 
investigation. 
Limitations 
This doctoral study had a number of limitations.  Kirkwood and Price (2013) 
explained that limitations represent deductions in the absence of proof.  The limitations of 
this study were the number of participants and representativeness of the industry in the 
study. 
The number of participants interviewed in this multiple case study was a 
limitation.  The risk associated with having a small number of participants correlates with 
the type of case study design.  The population of SCM executives formed each individual 
case study for this multiple case study.  A case study is an empirical exploration of a 
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phenomenon (Yin, 2014).  A single case study is an investigation of a phenomenon based 
on a single case while a multiple case study is an investigation of a phenomenon 
occurring in multiple cases.  The multiple case study is less susceptible to limitations than 
a single case study design (Yin, 2014).  Yin (2014) described a multiple case study 
design as a robust and compelling way for researchers to use two or more cases studies to 
conduct research.  The purpose of this multiple case study design was to explore and 
synthesize a contemporary phenomenon occurring in organizations within the medical 
device industry.  The limitation is the qualitative methodology used to explore an under-
researched phenomenon in a niche industry. 
Delimitations 
This doctoral study had a number of delimiting factors.  Dusick (2015) defined 
delimitations as boundaries within the researcher’s control.  The delimitations for this 
study were the population and geographic location.  The population for this study was 
SCM executives working in the medical device industry who had 5 years of CCM 
experience. 
I selected the geographic locations for this multiple case study based on the 
following factors.  The medical device industry for rapid diagnostic testing is a niche 
industry, which justifies the broadest geographical consideration to protect the 
confidentiality of companies and participants.  Thus, SCM executives must have a 
national or global understanding of the phenomenon because regional views are too 
narrow in scope. 
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Significance of the Study 
Students who publish business doctoral studies may contribute to business 
practices and social change.  My doctoral study is significant for its potential 
contributions to the practice of CCM in the medical device industry.  The identification 
and adoption of CCM strategies by SCM executives may prevent a medical device 
failure, which improves patient safety. 
Contribution to Business Practice 
Medical errors have become one of the foremost causes of patient injury and 
death throughout the world (Zineldin, Zineldin, & Vasicheva, 2014).  DMDs contribute 
to medical errors, which cost the U.S. health care system $17.1 billion in 2008 (Van Den 
Bos et al., 2011).  SCM executives who enhance their CCM acumen may increase the 
profitability of their organization through improved product reliability and regulatory 
compliance.  Improvements to business practices could also include functional areas in an 
organization, such as research and development (R&D) and SCM. 
R&D executives may perform new stability testing on DMD tests and controls to 
improve profitability.  For example, R&D executives may consider broadening the 
temperature ranges for new DMD tests and controls, which could reduce or eliminate the 
need for refrigerated shipments.  R&D executives may also perform a cost-benefit 
analysis to justify new stability studies on existing DMD tests and controls to reduce 
supply chain costs. 
Managers ensure temperature-sensitive products arrive at the customer on time 
and in good condition (Lis et al., 2009).  SCM executives who oversee managers have the 
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responsibility for ensuring temperature-sensitive DMD tests and controls arrive at the 
final destination without temperature excursions.  SCM executives may improve business 
practices that reduce supply chain costs while mitigating the risk of temperature 
excursions.  SCM executives who increase their CCM acumen may improve business 
practices by adopting CCM strategies that increase the use of validated CCSSs.  The 
procurement or development of validated CCSSs may give SCM executives increased 
transit time flexibility when shipping DMDs, which may improve shipping strategies.  
New shipping strategies for DMDs may improve product quality and safety while 
reducing supply chain costs.  For example, a decrease in transit time could reduce DMD 
exposure to extreme heat and or cold, which would improve product quality.  Conversely, 
an increase in transit time could reduce shipping costs through the optimization of less 
expensive transportation modes. 
Implications for Social Change 
SCM executives can improve patient safety by adopting CCM strategies by using 
innovative CCSSs designed to mitigate temperature excursions for DMD tests and 
controls (O’Connell et al., 2012; Smit et al., 2013).  A decline in injuries and deaths 
associated with medical device failures may correlate to a reduction in FDA recalls, 
liability claims, and legal proceedings against the medical device industry.  Reduction of 
FDA recalls and litigations may encourage medical device executives to invest in new 
business opportunities.  The funding of new business opportunities may increase 
manufacturing capacity and support R&D advancements in medical device technology.  
Such a shift may create new jobs, reduce health care costs, and bring to market new 
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diagnostic technologies that could save additional lives or improve patients’ standard of 
living.  Better CCM may increase profitability, patient safety, and technological 
advancements in DMDs. 
A Review of the Professional and Academic Literature 
Proper CCM can prevent temperature excursions to DMD tests and controls that 
contain temperature-sensitive proteins, antigens, and assays (O’Connell et al., 2012; 
Pruett et al., 2014; Smit et al., 2013).  Exploring the reasons SCM executives select 
certain CCSSs in the medical device industry could reveal new strategies in CCM.  The 
identification of CCM strategies could provide insight into the proper temperature control 
of DMD test and controls.  Conversely, improper CCM could cause temperature 
excursions to DMD test and controls, which could lead to medical errors that adversely 
affect patient outcomes.  The purpose of this qualitative multiple case study was to 
answers the following research question: What strategies do SCM executives use to ship 
temperature-sensitive DMD tests and controls?  Answering the research question required 
a thorough review of scholarly literature.  The literature review includes the framework 
and rationale for conducting this study. 
The search strategy for the literature review included analysis of the literature 
related to the conceptual framework and study topic, followed by the recognition of key 
words to characterize each theme.  These key words and terms became the searchable 
inputs into Walden’s library databases.  The steps of this top-down search strategy of 
themes, key words, and phrases were as follows. 
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The first step was to classify the literature review themes.  The five themes were 
(a) conceptual framework of the six-change approaches model, (b) CCM from a 
distribution perspective, (c) regulatory requirements governing the medical device 
industry, (d) SCM executives’ influence on CCM, and (e) overview of cognitive 
mapping.  The selection of these five themes allowed me to understand the phenomenon 
of how and why DMD tests and controls lack standardized shipping practices in the 
medical device industry from a peer/practical review and scholarly perspective.  More 
importantly, these five themes helped me develop a set of effective interview questions 
needed to explore the phenomenon with SCM executives who have responsibilities for 
CCM in the medical device industry. 
The next step was the identification of key words and phrases for each theme.  I 
summarize these key words and phrases in Table 2.  These key words and phrases 
became the inputs into searches of databases accessible through the Walden University 
library.  The databases accessed in this study were Thoreau, ProQuest Central, 
ABI/INFORM Complete, ScienceDirect, Science Citation Index Expanded, ERIC, and 
LexisNexis Academic. 
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Table 2 
Key Words and Phrases Used in Databases Searches 
Key words Phrases 
Cold chain management 
Cold chain shipping 
Diagnostic device 
Diagnostic tests 
Diagnostic controls 
Food and Drug 
Administration/FDA 
World Health Organization 
Conformité Européenne 
Product stability 
Cognitive mapping 
Concept mapping 
Six-change approaches model 
Catalytic innovation 
Distribution 
Warehousing 
Transportation 
Validations 
History of cold chain management 
Challenges of cold chain management in the medical 
device industry 
Product stability of diagnostic medical devices 
Diagnostic tests and the effects of extreme heat and 
cold 
Food and Drug Administration governance of the 
medical device industry 
Cold chain management of diagnostic medical 
devices (DMD) tests and controls 
Cold chain management education and seminars 
Using Decision Explorer as a research instrument 
Distribution of temperature sensitive DMDs 
Warehousing of temperature sensitive DMDs 
Transportation of temperature sensitive DMDs 
Validating temperature sensitive DMD test and 
controls 
The final step was to analyze and synthesize the literature from the databases.  I 
then organized the literature review by themes and subthemes. 
The first theme was the conceptual framework used to conduct the study.  I used 
the six-change approaches model as the conceptual framework for the study.  The 
conceptual framework of the study helped me create a systematic view of the 
phenomenon. 
The second theme was CCM from a distribution perspective.  The second theme 
had two supporting subthemes.  The subthemes included the challenges associated with 
CCM and cold chain layouts and design. 
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The third theme was the regulatory requirements governing the medical device 
industry.  The third theme had three supporting subthemes.  The subthemes were the 
nature and scope of medical device regulations, the impact of regulations on the medical 
device industry, and the regulatory gaps in the medical device industry. 
The fourth theme was the influences of SCM executives on CCM.  The fourth 
theme had supporting subthemes that provided additional insight into the propositions 
associated with this study.  The subthemes were CCSSs used in the medical device 
industry, organizational and educational requirements in the medical device industry, and 
the distribution requirements of DMD tests and controls from a regulatory and stability 
perspective. 
The fifth theme was cognitive mapping.  The fifth theme had two supporting 
subthemes.  The subthemes were cognitive mapping and the scholarly applications of 
cognitive mapping.  The organization of themes and subthemes are in Figure 1. 
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Figure 1. Themes and subthemes. 
The literature review addresses the themes and subthemes that support the 
propositions and interview questions designed to answer the research question.  In 
addition, the literature review includes an analysis of studies that helped me understand 
the phenomenon.  I based this study on 131 references, with 84 references contributing to 
the literature review.  Of those 131 references, 94% were from peer-reviewed sources at 
the anticipated completion date of this doctoral study, as shown in Table 3. 
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Table 3 
Synopsis of Sources Used in the Literature Review 
 Age of references based on anticipated graduation 
Reference type Total < 5 years > 5 years 
Peer-reviewed articles 124 108 16 
Non-peer-reviewed articles 0 0 0 
Dissertations 0 0 0 
Books 2 2 0 
Other 5 2 3 
Totals 131 112 19 
Conceptual Framework of Six-Change Approaches Model 
CCM in the medical device industry could become stagnant without innovation.  
Reddy, Malliyala, Naresh, Raghunandan, and Jinadatharaya (2012) found that effective 
CCM involves good storage and distribution practices.  Innovation in cold chain shipping 
and widespread adoption of innovation is a necessity given the critical nature of 
temperature-sensitive DMD tests and controls.  The first theme in the literature review is 
the conceptual model of six-change approaches. 
I used Kotter and Schlesinger’s (1979) six-change approaches (SCA) model as the 
conceptual framework for this study.  The premise of the SCA model is leaders need to 
manage issues based on the internal and external forces that disrupt the status quo of 
people in an organization (Kotter & Schlesinger, 1979).  The SCA model is a strategy 
that leaders can use to prevent or decrease an individual or group’s resistance to change 
(Kotter & Schlesinger, 1979). 
Kotter and Schlesinger (1979) defined six propositions to support the SCA model.  
The first proposition of the SCA model is education and communication.  Leaders 
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commonly use education and communication to persuade employees to accept 
organizational change when there is a lack of information or information is interpreted 
inaccurately (Kotter & Schlesinger, 1979).  The education and communication 
proposition is time-consuming to implement because leaders must engage most 
employees throughout the organization (Kotter & Schlesinger, 1979). 
The second proposition of the SCA model is participation and involvement.  
Leaders commonly use participation and involvement to secure employee ideas and 
commitment to change (Kotter & Schlesinger, 1979).  Leaders typically use participation 
and involvement when they lack the necessary information to design the change, and 
there is considerable resistance to the change (Kotter & Schlesinger, 1979).  The 
participation and involvement proposition is time-consuming to implement because 
leaders must use employee participants to develop the appropriate organizational change 
(Kotter & Schlesinger, 1979). 
The third proposition of the SCA model is facilitation and support.  Leaders 
commonly use facilitation and support to help employees with adjustment problems to 
adapt to organizational change (Kotter & Schlesinger, 1979).  The facilitation and support 
proposition is time-consuming and expensive to implement because leaders may need to 
provide new skills training, time off, listening sessions, and emotional support (Kotter & 
Schlesinger, 1979). 
The fourth proposition of the SCA model is negotiation and agreement.  Leaders 
commonly use negotiation and agreement to avoid resistance to change by meeting the 
demands of an individual or group who have considerable power to resist change (Kotter 
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& Schlesinger, 1979).  The negotiation and agreement proposition is expensive to 
implement because leaders create an organizational culture that encourages compliance 
through negotiations (Kotter & Schlesinger, 1979). 
The fifth proposition of the SCA model is manipulation and co-optation.  Leaders 
commonly use manipulation and co-optation to counteract resistance to change by 
providing select information to employees or giving an individual from an influential 
group a key position in exchange for his or her endorsement of the proposed 
organizational change (Kotter & Schlesinger, 1979).  The manipulation and co-optation 
proposition is an inexpensive and easy way to obtain the support of organizational change 
by an individual or group (Kotter & Schlesinger, 1979).  The downside of this 
proposition is that leaders who use manipulation and co-optation must contend with 
employees feeling tricked or lied to (Kotter & Schlesinger, 1979). 
The sixth proposition of the SCA model is explicit and implicit coercion.  Leaders 
commonly use explicit and implicit coercion to overcome all resistance to change by 
threatening an individual or group with termination, job transfer, and loss of promotional 
opportunities (Kotter & Schlesinger, 1979).  Leaders who use the explicit and implicit 
coercion proposition cause employees to have resentment, which may result in new 
resistance to change (Kotter & Schlesinger, 1979). 
I used relevant propositions from the SCA model to ground the case study.  These 
propositions guided the construct of how and why interview questions.  SCM executives 
may use the insight gained from interview questions to support the implementation of 
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CCM strategies in their respective organizations.  However, some SCM executives may 
resist change in their organization, based on CCM misconceptions. 
Kotter and Schlesinger (1979) theorized two misconceptions that prevent change.  
First, people resist change when they do not understand the implications of a problem 
based on a misunderstanding or a lack of trust (Kotter & Schlesinger, 1979).  People also 
resist change when they incorrectly analyze a problem and determine that the cost of 
change is more expensive than they originally anticipated.  SCM executives who 
misunderstand or fail to assess a problem are more likely to form misconceptions that 
prevent change.  I was able to identify three CCM misconceptions of SCM executives 
from the literature. 
The first misconception of SCM executives is that the addition of a few gel packs 
at room or frozen temperature into Styrofoam coolers meets the temperature stability 
requirements for national and global distribution of DMD tests and controls (Hidestrand 
et al., 2012; Jansen et al., 2010).  The second misconception of SCM executives is the use 
of existing CCSSs meets the regulatory owner or regulatory compliance requirements, 
even though these solutions lack empirical evidence that supports temperature control 
(Jadhav, Gholve, & Kadam, 2009).  The third misconception of SCM executives is that 
the act of improving existing CCSSs might cost too much money (Joshi, Banwet, 
Shankar, & Gandhi, 2012).  SCM executives who understand the underpinnings of the 
SCA model are more likely to identify misconceptions that may prevent the 
implementation of new CCM strategies in their organization.  SCM executives must 
educate and align people with CCM strategies to prevent misconceptions that impede 
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change.  SCM executives working in the medical device industry should have direct 
responsibility for CCM strategies.  With this responsibility, SCM executives who use the 
SCA model could improve business strategies in their organization.  
I considered a variety of models and theories to ground the conceptual framework 
of the study.  Theories help researchers make sense of a phenomenon of interest 
(Chicksand, Watson, Helen, Radnor, & Johnston, 2012).  The rival theory to the 
conceptual model of SCA is catalytic innovation.  Leaders who use catalytic innovation 
theory can achieve social change on a national scale (Christensen, Baumann, Ruggles, & 
Sadtler, 2006). 
Leaders have an inherent resistance to social change that prevents organizations 
from realizing catalytic innovation (Christensen et al., 2006).  Resistance to social change 
is a fundamental premise of the catalytic innovation theory.  The premise for preventing 
catalytic innovation is that leaders in all industries prefer to maintain existing practices, 
which makes it difficult to change or improve upon those practices (Christensen et al., 
2006).  For example, executives maintain existing practices because the act of making 
any change to those practices disrupts them or their teams (Christensen et al., 2006).  
Leaders’ resistance to catalytic innovation might prevent their organization from 
improving business strategies because those strategies relate to social change.  Moreover, 
leaders can develop a good-enough mindset toward the optimization of existing business 
practices and processes.  For example, a leader with a good-enough mindset believes 
improving existing business practices would lead to organizational disruption, which is 
unacceptable to the status quo (Christensen et al., 2006). 
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Christensen et al. (2006) found that business leaders who resist catalytic 
innovation with their good-enough mindsets also fail to address social problems.  On the 
other hand, Lee, Trimi, and Kim (2013) concluded the catalytic innovation of goods and 
services could drive quicker adoption, which could then change the behavior of an entire 
industry.  Furthermore, Klassen and Vereecke (2012) established that SCM executives 
could actively mitigate social challenges by improving SCM practices.  Therefore, SCM 
innovation correlates with a leader’s ability to identify and eliminate the behavioral 
patterns that prevent catalytic innovation. 
Although catalytic innovation theory is a supportive conceptual framework 
applicable to this research, the conceptual model of SCA was more fitting for this study.  
I used the SCA model to explore and gain insight into the methods that SCM executives 
used to address resistance to change and the various choice strategies that helped them to 
overcome resistance to change (Kotter & Schlesinger, 1979).  The SCA model includes 
methods of organizational change management for SCM executives working in the DMD 
industry who are interested in adopting CCM strategies designed to increase patient 
safety. 
Cold Chain Management From a Distribution Perspective 
In conducting this literature review of CCM, I discovered many industries in 
which leaders demonstrated a proficient level of understanding.  My new level of 
understanding of CCM added creditability and led to new insights into CCM strategies.  
The second theme in the literature review is the challenges associated with CCM and cold 
chain layout and design. 
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CCM involves two levels of problem solving.  The strategic level includes a broad 
plan of action and a tactical or operational level that renders the means for carrying out 
the prescribed strategy.  At the tactical level, SCM practitioners use product labeling to 
identify the proper CCSSs needed to maintain product temperature.  The failure to 
maintain proper temperatures could affect assay performance, which could lead to a 
diagnostic error (Raizada et al., 2014).  The use of faulty DMD tests and controls 
increases the probability of clinical misdiagnoses.  As a result, SCM executives are under 
immense pressure to select the most appropriate CCSSs.  The proper selection of CCSSs 
depends on the SCM executive’s knowledge of CCM at both the strategic and tactical 
level. 
Reddy, Malliyala, Naresh, Raghunandan, and Jinadatharaya (2012) asserted that 
CCM is required for maintaining the shelf life of agricultural products, frozen foods, 
chemicals, and pharmaceuticals.  SCM practitioners use CCM practices in the delivery of 
fresh produce and meats, frozen foods, industrial chemicals, pharmaceuticals, biologicals, 
and medical devices.  CCM involves the continuous temperature control of perishable 
and temperature-sensitive goods in the supply chain.  Uçar and Özçelik (2013) found that 
consumers of cold chain products were unfamiliar with proper refrigeration and labeling.  
The proper distribution and storage of perishable and temperature-sensitive goods 
throughout the supply chain requires SCM practitioners to use a variety of CCSSs, 
refrigerators, and freezers. 
CCSS designs vary from passive to active temperature control.  Hidestrand et al. 
(2012) used a Styrofoam box and gel packs to protect products from extreme 
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temperatures during transit.  Reddy et al. (2012) explained that SCM practitioners used 
dry ice, phase change, and ice packs to maintain product temperatures.  Passive CCSSs 
consist of thermal blankets, Styrofoam coolers, polyurethane coolers, vacuum insulated 
panel shippers, phase change shippers, dry ice shippers, and nitrogen shippers.  In 
addition, passive shipping solutions use various types of refrigerant, such as gel packs, 
foam bricks, phase change panels, dry ice, and nitrogen to maintain product temperature 
for a fixed duration of time.  Hidestrand et al. concluded the distance to a shipping 
location and weather could adversely influence product quality.  The amount of time a 
passive shipping solution can maintain product temperature is dependent on its packaging 
design, exposure to external temperatures, and transit time. 
In contrast to passive CCSSs, active CCSSs have integrated technologies 
designed to monitor and regulate product temperature to counteract the effects of external 
temperatures during transit.  Active shipping solutions can mitigate the effects of extreme 
heat and cold.  An active shipping solution is essentially a refrigerator or freezer that is 
transportable.  Liu, Higgins, and Tan (2012) found that SCM practitioners use 
refrigerated trucks to transport temperature-sensitive products.  Transportable refrigerated 
solutions can range from ocean containers, railcars, tractor trailers, pallet-sized bulk 
containers, or unit load devices. 
SCM practitioners use active and passive CCSSs to transport goods domestically 
and internationally (White & Cheong, 2012).  It is likely that SCM executives use various 
active and passive shipping solutions to distribute temperature-sensitive DMD tests and 
controls globally.  SCM executives select CCSSs based on the product labeling and 
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distance.  For example, temperature-sensitive products in the medical device industry 
require specialized storage and distribution practices throughout the supply chain.  
Therefore, SCM practitioners in the medical device industry use CCM practices to store 
and distribute temperature-sensitive DMD tests and controls. 
Reddy et al. (2012) remarked SCM practitioners find it increasingly important to 
use proper storage, handling, and distribution for temperature-sensitive products.  SCM 
practitioners employ specialized storage, packaging, refrigerant, and transportation 
throughout the storage and distribution process.  Packing engineers have designed 
specialized cold chain solutions to mitigate the effects of hot and cold weather and 
mechanical temperatures on DMD tests and controls from the factory to the clinician.  
Reddy et al. found that effective CCM involves good storage and distribution practices.  
The global distribution of DMD tests and controls to clinicians often require extensive 
CCM strategies.  SCM executives take into consideration the modes of transportation, 
refrigeration strategies, transit times, and weather conditions when developing CCM 
strategies.  Transportation modes for shipping products can range from ocean to rail, 
road, and air.  Transportation modes of transportation also require a refrigeration strategy.  
Refrigeration strategies consist of active and passive CCSSs.  CCSSs must account for 
transit time and weather conditions to ensure DMD tests and controls maintain their 
specified temperatures during transit.  SCM practitioners face numerous challenges to 
employing specialized storage, packaging, refrigerant, and transportation throughout the 
supply chain. 
28 
 
Challenges associated with cold chain management.  The challenges associated 
with CCM affect a wide spectrum of industries.  To understand these challenges, I 
explored CCM from a historical perspective across various industries.  My exploration 
into CCM from a historical perspective provided scholarly insights into the phenomenon 
associated with this study.  The historical evolution of CCM could potentially help SCM 
practitioners in their decision making. 
Rees (2013) noted that the earliest form of CCM was the manufacturing of ice in 
underground icehouses, which dates back to 1100 BCE in China.  In the early 1800s, 
Tudor created the natural ice industry (Rees, 2013).  The natural ice industry quickly 
became a societal necessity.  The use of salt, drying, smoking, and preservatives (sulfuric 
acid, borax, and formaldehyde) destroyed the nutrients in food and caused serious health 
problems, including botulism (Rees, 2013).  
During the Industrial Revolution, leaders in the food industry used natural ice to 
mitigate some of the health risks associated with preservatives.  The Industrial 
Revolution led to new and innovative manufacturing processes, many of which benefited 
the natural ice industry.  Innovations in the natural ice industry were critical to the 
agriculture, restaurant, storage, and distribution industries in the 1870s–1920s because of 
extreme pressures to improve food safety (Rees, 2013).  The storage and distribution 
industries were able to achieve steady advancements in cold chain technology as it relates 
to the control and monitoring of perishable goods throughout the supply chain (Rees, 
2013).  Advancements in cold chain technology helped reduce temperature excursions 
(Stanger, Wilding, Yates, & Cotton, 2012) and helped to modernize the CCM practices 
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used by the pharmaceutical, biological, and medical device industries (Rees, 2013).  The 
classification of CCM practices typically resides in the body of knowledge for CCM or 
SCM. 
Some scholars dispute the classification of CCM practices.  For instance, Raab, 
Petersen, and Kreyenschmidt (2011) believed CCM practices require additional 
information for handling perishable products, while SCM only requires the exchange of 
product information from the transaction to the location.  Conversely, Diehl and Spinler 
(2013) concluded that SCM starts with the sourcing of materials from suppliers to the 
fulfillment of manufactured products to customers.  Stanger et al. (2012) suggested that a 
transfusion laboratory manager is responsible for the SCM activities of forecasting, 
sourcing, inventory control, quality, and CCM.  The lack of continuity among scholars 
could cause a difference in opinion of whether CCM practices exist within or without the 
context of SCM.  Differences in opinion among scholars could cause confusion in the 
cold chain and or supply chain bodies of knowledge.  This potential for confusion 
increases the need to define CCM. 
CCM is the continuous temperature control and monitoring of perishable and 
temperature-sensitive goods such as fresh produce and meats, frozen foods, industrial 
chemicals, pharmaceuticals, biologicals, and DMD tests and controls.  The literature 
contains various other scholarly definitions of CCM.  For example, Joshi et al. (2012) 
defined CCM as a linear process that starts with the complete temperature control of 
produce from the harvest to the end consumer. 
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Temperature control is active or passive.  Active temperature control requires 
temperature monitoring and active temperature control to ensure product quality and 
shelf life (Raab et al., 2011).  Jadhav et al. (2009) concluded that actively refrigerated 
trucks, cars, ships, containers, and passively controlled shipping containers need 
validating.  Passive CCSSs lack proactive regulation of temperature during transit (Raab 
et al., 2011).  SCM practitioners have industry-specific challenges relative to active and 
passive temperature control; these challenges affect a multitude of industries, such as the 
food, chemical, pharmaceutical, biological, and medical device industry. 
Leaders in the food industry face a variety of risks on a global scale.  For 
example, the food industry must contend with product recalls based on the magnitude of 
the food safety risk (Wang, Li, & Shi, 2012).  Consumers also pose a risk to food safety.  
Uçar and Özçelik (2013) found that consumers are not familiar with their responsibilities 
for the proper CCM of the food they purchase and consume.  Moreover, consumers are 
not aware of the proper temperature requirements for their refrigerator, which could 
result in a foodborne illness (James, Onarinde, & James, 2017).  The lack of consumer 
knowledge in CCM and proper refrigeration may adversely affect the safety and cost of 
food (Shukla & Jharkharia, 2013; Uçar & Özçelik, 2013).  Overall, CCM challenges are 
more prevalent in developing countries than in industrialized countries (Joshi et al., 
2012). 
The pharmaceutical, biological, and medical device industries must conduct 
clinical trials and receive FDA approval before bringing new products to market.  
Clinical trials that include CCM requirements are complex.  SCM practitioners must 
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devise CCM strategies to overcome the long lead times associated with personalized 
medicines and small-molecule drugs that must reach the final destination on time, 
untampered, and at the right temperature (Hager, 2011).  For example, poor CCM could 
result in temperature excursions that could alter the efficacy of samples used in clinical 
trials (Hager, 2011).  Therefore, SCM practitioners must have the logistical expertise to 
manage the global shipping of temperature-sensitive products (Hager, 2011). 
SCM executives working in the pharmaceutical industry must overcome the CCM 
challenges associated with over-the-counter and prescription drugs.  CCM challenges 
consist of increased shipping volumes, diverse product temperature requirements, and the 
complexity of global logistic (Reddy et al., 2012).  Despite these challenges, SCM 
executives should focus on introducing cross-industry CCM strategies to their respective 
organizations.  The adoption of cross-industry CCM strategies by SCM executives could 
mitigate known and unknown CCM issues. 
Cold chain layout and design.  SCM executives must be knowledgeable about 
CCM strategies to coordinate the storage and shipping of temperature-sensitive DMD 
tests and controls nationally and globally.  Reddy et al. (2012) found that effective CCM 
involves good storage and distribution practices throughout the global supply chain.  
CCM strategies must take into consideration all activities from inbound sourcing of 
temperature-sensitive raw materials to the factory through the distribution of temperature-
sensitive DMD tests and controls to the clinician. 
CCM strategies must incorporate active and passive temperature control for the 
storage and shipping of DMD tests and controls throughout the supply chain.  Hidestrand 
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et al. (2012) found that weather could adversely influence product quality.  Therefore, 
CCM strategies must be capable of mitigating weather conditions of extreme heat and 
cold from the beginning of the supply chain to the end.  To address this requirement, 
SCM practitioners can develop cold chain maps to document the temperature profiles for 
the proper storage and shipping of temperature-sensitive products.  Cold chain maps are 
an example of the performance improvement systems managers can use to reduce the 
complexity of maintaining CCM strategies (Joshi et al., 2012).  Effective CCM requires 
SCM executives to understand cold chain mapping strategies. 
The cold chain mapping of a DMD supply chain begins with the identification of 
each waypoint in the supply chain and the length of time a product dwells at each 
waypoint.  I first elaborate on how I have performed cold chain mapping and then 
illustrate the process (see Figure 2).  Cold chain mapping of a DMD supply chain 
requires the identification of the final waypoint or destination, which is typically the 
clinician’s office or hospital.  Next, there is a need to identify the waypoints that 
represent the physical structures in which products may dwell, such as factories, 
warehouses, and hospitals.  Then, there is a need to identify the most optimal route and 
time for transporting products to the clinician or hospital.  Then, the selection of active 
and passive shipping solutions to ensure products maintain their temperature 
requirements must be determined.  Finally, there is a need to identify each mode of 
transportation for moving products through each waypoint in the supply chain. 
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Figure 2. Global distribution of temperature-sensitive DMD tests and controls. 
SCM practitioners can create temperature profiles to help determine the most 
effective shipping solutions for transporting temperature-sensitive DMD tests and 
controls.  The development of temperature profiles requires SCM practitioners to identify 
the storage and shipping temperatures for DMD tests and controls.  In addition, SCM 
practitioners must collect weather data to extrapolate the external temperature ranges for 
each waypoint on the cold chain map.  Furthermore, SCM practitioners need to isolate 
active or passive temperature control solutions used to transport products through each 
waypoint in the supply chain.  Cold chain mapping gives SCM executives the ability to 
understand the most optimal CCM strategy.  I developed a second cold chain mapping 
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illustration based on workflows, locations, temperatures, and transits times (see Figure 3).  
Optimal CCM strategies help SCM executives in the development and procurement of 
validated CCSSs. 
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High °C High °F Sate/Country Low °C Low °F Sate/Country Duration Changes Time Time
1 Pick order 20 68 Controlled 20 68 Controlled 0.75 8:00 AM 8:45 AM
2 QC order 20 68 Controlled 20 68 Controlled 0.5 8:45 AM 9:15 AM
3 Pack order 20 68 Controlled 20 68 Controlled 0.75 9:15 AM 10:00 AM
4 Hold in DC for pickup 20 68 Controlled 20 68 Controlled 6 10:00 AM 4:00 PM
5 Carrier collection at DC 20 68 Controlled 20 68 Controlled 0.5 8.5 4:00 PM 4:30 PM
6 Transport to carrier DC 26 78.8 California 6 42.8 California 0.5 9 4:30 PM 5:00 PM
7 Carrier sort 20 68 California 20 68 California 1.5 10.5 5:00 PM 6:30 PM
8 Transport to airport/ramp 26 78.8 California 6 42.8 California 0.5 11 6:30 PM 7:00 PM
9 Loading of aircraft 20 68 California 6 42.8 California 2 13 7:00 PM 9:00 PM
10 Air 5 41 Controlled 5 41 Controlled 4 17 9:00 PM 1:00 AM
11 Unload and sorted 23 73.4 Indiana or Tenessee 1 33.8 Indiana or Tennessee 3 20 1:00 AM 4:00 AM
12 Hold in carrier DC 20 68 Indiana or Tenessee 20 68 Indiana or Tennessee 4 31 4:00 AM 8:00 AM
13 Deliver 29 84.2 NA -10 14 NA 3 34 8:00 AM 11:00 AM
27
11a Connection upload 23 73.4 Indiana or Tenessee 1 33.8 Indiana or Tennessee 1.5 21.5 4:00 AM 5:30 AM
11b Air 5 41 Controlled 5 41 Controlled 4 25.5 5:30 AM 9:30 AM
11c Unload and sorted 29 84.2 NA -10 14 NA 1 26.5 9:30 AM 10:30 AM
11d Transport to carrier DC 29 84.2 NA -10 14 NA 0.5 27 10:30 AM 11:00 AM
34
14 Clinicians 20 68 Controlled 20 68 Controlled 38 72
72  
Note. SCM practitioners develop temperature models utilizing various data sources, 
such as the International Safe Transit Association (ISTA), National Oceanic and 
Atmospheric Administration (NOAA), and transportation carriers (ocean, road, rail, 
and or air) to define temperature variations (hot and cold) that perishable and 
temperature-sensitive products may encounter during transit.  SCM practitioner’s use 
temperature models for the design and or validation of CCSSs. 
Figure 3. Cold chain temperature model. 
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Regulatory Requirements Governing the Medical Device Industry 
The medical device industry must comply with a multitude of regulations on a 
global basis.  The third theme in the literature review is the nature and scope, impact, and 
gaps associated with global medical device regulations.  The literature provided insights 
into the regulatory requirements and challenges associated with the phenomenon that was 
the focus of this study. 
Nature and scope.  The FDA began regulating the medical device industry in 
1938 (Challoner & Vodra, 2011).  In the 1970s, the FDA found that the existing 
regulatory governance of medical devices was no longer suitable for the level of 
innovation occurring in the medical device industry (Challoner & Vodra, 2011).  As a 
result, Congress passed the Medical Device Amendment of 1976, which established the 
current regulatory framework for the medical device industry in the United States 
(Challoner & Vodra, 2011). 
The FDA regulates medical device registration, listing, premarket approval, 
510(k), quality system adherence, and good manufacturing practices (FDA, 2006).  FDA 
(2006) regulations require medical device manufacturers to document the storage and 
shipping requirements of their products.  Agents for the FDA require all medical devices 
to have regulatory clearance before any sales or distribution activities occur in the United 
States (Alfa, 2013).  The FDA uses regulatory standards to govern the medical device 
industry.  For example, the FDA uses the PMA and 510(k) processes to regulate the 
medical device industry (Kramer et al., 2012a).  The PMA regulation requires clinical 
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testing and inspection approval before the sale of any new medical device.  Clinical trials 
must meet the scientific standards set in the Belmont report (Berry, 2015).  In contrast, 
510(k)-cleared medical devices must be substantial equivalents to existing medical device 
technology (Kramer et al., 2012a).  Clearance of the 510(k) process deems that a new 
medical device is equivalent to a pre-existing approved medical device (Challoner & 
Vodra, 2011).  Therefore, a medical device that is a substantial equivalent is as safe and 
effective as the previously approved medical device (Challoner & Vodra, 2011). 
The FDA is responsible for defining medical devices.  The FDA views a medical 
device as anything that performs the diagnosis of disease, condition, cure, mitigation, 
treatment, and prevention in humans and animals (Reed & Kaufman-Rivi, 2010).  There 
are three different classes of medical devices: Class I devices are low risk, Class II 
devices are a moderate risk, and Class III devices are high risk (Kramer et al., 2012a).  In 
1996, the FDA started tracks event problem codes associated with medical device failures 
by class.  Event problem codes give consumers, health care professionals, and device 
manufacturers access to medical device failures via the MedWatch reporting system 
(Reed & Kaufman-Rivi, 2010).  Since 1996, the FDA has recorded millions of event 
problem codes; medical device malfunctions link the majority of these events (Reed & 
Kaufman-Rivi, 2010).  Medical device malfunctions could lead to the misdiagnosis of a 
patient, which could lead to injury or death. 
Like the FDA, the European Union (EU) has several classifications of medical 
devices.  The EU oversees the classifications of medical devices through a dual 
regulatory approach.  The EU Competent Authority is responsible for approving all low-
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risk medical devices while notified bodies approve all high-risk medical devices (Kramer 
et al., 2012b).  The EU regulatory authorities require medical devices to display 
Conformité Européenne (CE) markings to signify that these devices are safe and fit for 
their intended purpose (Kramer et al., 2012a).  Each EU member state must enforce these 
regulations (Heneghan, Thompson, Billingsley, & Cohen, 2011). 
The FDA and EU Competent Authority usually represent industrialized countries.  
Consequently, developing countries typically rely on the World Health Organization 
(WHO) for the prequalification of medical devices (Jaros & Saberwal, 2013).  
Developing countries rely on the WHO because these countries lack local regulations 
governing medical device innovation (Jaros & Saberwal, 2013). 
Impact of regulations.  The policies that govern the medical device industry 
have both positive and negative consequences.  These positive and negative 
consequences affect the safety of patients and the speed of innovation.  For example, the 
Center for Devices and Radiological Health (CDRH) is a department in the FDA that is 
responsible for regulating the medical device industry.  Agents for the CDRH 
aggressively regulate the medical device industry (Cruise, 2011).  Agents for the FDA 
issue warning letters to increase public knowledge and place pressure on medical device 
companies to comply.  Some consumer advocate groups believe that the FDA has not 
effectively managed the medical device industry from an oversight and approval 
perspective (Cruise, 2011).  The CDRH responded to this criticism by implementing a 
total product life cycle methodology to manage medical devices, which should help 
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reduce medical device failures (Cruise, 2011).  Medical device recalls increased 108% 
over a 7-year period, from 572 recalls in 2005 to 1,190 recalls in 2012 (Sullivan, 2014).   
The issuance of 510(k) approvals by the FDA may lead to innovative technology 
that improves testing outcomes at the expense of overly complicated medical devices 
(Suter et al., 2013).  Challoner and Vodra (2011) asserted 510(k) clearances issued by the 
FDA are insufficient to ensure patient safety.  As reinforcement to their claim, Challoner 
and Vodra found that several thousand medical devices are approved by the FDA each 
year, with one-third being approved by the 510(k) process without significant evidence 
that the new product is a substantial equivalent.  This lack of regulatory oversight could 
adversely affect patient safety.  Patient safety concerns are global, and the effect of these 
concerns impacts both industrialized and developing countries. 
In the EU, the Competent Authority addresses patient safety issues through the 
CE process because malfunctioning medical devices cause patient harm.  Government 
authorities in the United Kingdom reported 447 medical device alerts between 2006 and 
2010, and nearly half of the alerts resulted in serious adverse health consequences or 
death (Heneghan et al., 2011).  Medical device recalls that adversely affect patient safety 
are on the rise in the United Kingdom.  Although the existence of the data are known, 
there is a lack of transparency in the data associated with these recalls; this lack of 
transparency prevents the full understanding of how and why these failures occur 
(Heneghan et al., 2011). 
Agents for the WHO (as cited in Jaros & Saberwal, 2013) reported that nearly all 
modern medical devices used in developing countries come from industrialized countries 
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and that developing countries lack the infrastructure to ship these medical devices within 
their borders.  For example, India is a developing country that imports more than 75% of 
its medical devices from the West (Jaros & Saberwal, 2013).  The lack of cold chain 
infrastructure in developing countries could result in temperature excursions during the 
storage and distribution of DMD tests and controls. 
Regulatory gaps.  Government agencies such as the WHO, FDA, and Competent 
Authority might lack regulatory policies that allow agents to enforce CCM compliance in 
the medical device industry.  Conversely, there are specific regulatory and product 
stability requirements directly associated with DMD tests and controls.  Smit et al. (2013) 
suggested that performance testing of diagnostic tests should focus on the accuracy of the 
results, reliability of equipment, cold chain requirements, and ease of use.  Despite the 
PMA and 510(k) approval process, there is a lack of consistency in performance testing 
in the medical device industry.  As such, medical device manufacturers can use 
temperature stability studies and accelerated aging methods to determine the shelf life of 
diagnostic tests (Goarant et al., 2013).  One objective of stability studies is to establish 
labeled storage temperatures on products (Schofield, 2009).  Stability studies also provide 
guidance related to product quality when a temperature excursion occurs in the supply 
chain (Schofield, 2009). 
Chemicals and reagents in DMD tests and controls react differently to high 
temperatures than to ambient or cold temperatures.  Stability studies help with 
determining thermal degradation (Dabhi et al., 2013).  Lateral flow diagnostic tests are 
susceptible to extreme temperature (Miller & Sikes, 2015).  Antigens used in DMDs are 
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susceptible to temperature, which could adversely affect the performance of DMD tests 
(Miller & Sikes, 2015). 
Reagents used in DMD tests may have various levels of thermal instability (Miller 
& Sikes, 2015).  Furthermore, diagnostic tests contain antibodies and macromolecules 
that become inactive when exposed to heat and humidity, which makes the adherence to 
product storage and shipping conditions critical to the proper functionality of medical 
device tests and controls (Bissonnette & Bergeron, 2012).  Similarly, storage conditions 
can adversely affect the stability of a drug (Lin, Hsu, & Lin, 2013). 
Stability testing revealed that some antibodies require strict CCM to prevent 
irreversible denaturation caused by high temperatures, which reduces shelf life 
(Wongphatcharachai et al., 2013).  For example, a robustness study might expose an 
assay to a temperature of 25–35 °C for a specific duration of time (Dabhi et al., 2013).  
Results of such a study might indicate that a particular assay used in DMD tests and 
controls would only be stable for 48 hours at room temperature or eight days at 4 °C 
(Dabhi et al., 2013).  In addition, diagnostic devices that require the use of DNA samples 
need to have cold chain practices that can support 4 °C storage and shipping (Sokhna et 
al., 2013).  Lastly, all products should have their storage temperatures specified on the 
label and or the primary packaging.  Temperature stability requirements create the need 
for specific CCSSs for the distribution of DMD tests and controls. 
Supply Chain Management Executives’ Influences on Cold Chain Management 
SCM executives have influences on CCM.  The fourth theme in the literature 
review is SCM executives’ influences on CCM strategies—more specifically, how SCM 
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executives influence CCSSs for the shipping of DMD tests and controls, organizational 
and educational requirements needed to ship medical devices, and the distribution 
requirements needed to ship temperature-sensitive DMD tests and controls from a 
regulatory and stability perspective.  Lastly, the synthesizing of these subthemes directed 
the study and helped further refine the interview questions needed to understand the 
propositions and the phenomenon (Yin, 2014). 
Cold chain shipping solutions used in the medical device industry.  SCM 
practitioners use cold chain strategies to store and ship temperature-sensitive products.  
CCM is the controlled methodology for properly storing and distributing temperature-
sensitive products (Reddy et al., 2012).  Effective CCM prevents temperature excursions.  
DMDs have product labeling to indicate appropriate storage temperatures (Maltha et al., 
2013).  Thus, SCM practitioners must adhere to product labeling as part of a CCM 
strategy. 
Cold chain shipping solutions are either active or passive.  Passive shipping 
solutions are less complex and offer some protection against extreme temperatures, as 
compared to active temperature-controlled shipping solutions.  For example, validated 
shipping solutions can protect products against extreme heat and cold (Jadhav et al., 
2009).  Validated shipping solutions are also cheaper than a truck on a per-unit basis.  
Agents for the FDA require passive shipping containers to have validation protocols 
(Jadhav et al., 2009).  Certified packaging laboratories use environmental chambers and 
temperature profiles to validate passive shipping containers (Jadhav et al., 2009).  
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Validated shipping solutions help eliminate temperature excursions that occur during the 
storage and shipping of temperature-sensitive products. 
Active CCSSs such as temperature-controlled trailers and containers can maintain 
product temperatures during transit (White & Cheong, 2012).  These active CCSSs offer 
real-time temperature control and monitoring, which reduces the likelihood of 
temperature excursions.  SCM practitioners using CCM strategies have fewer medical 
device failures from a temperature excursion perspective. 
SCM practitioners use refrigerants, such as gel packs, foam bricks, phase change 
panels, dry ice, and nitrogen to keep products within specified temperature ranges in 
CCSSs.  For example, some passive cold chain shipping containers use –20 °C gel packs 
to keep products in the 2–8 °C range during transit (Jansen et al., 2010).  Many 
companies mass-produce shipping containers for the medical device industry.  For 
example, Coleman manufactures several various types of passive cold chain shipping 
containers.  Coleman Model 5272 can maintain product temperatures below 10 °C for 35 
hours when utilizing two –20 °C gel packs, even when exposed to ambient temperatures 
(Jansen et al., 2010).  In some instances, customized CCSSs used in hot climates will 
only maintain temperature for 24 hours (Wei Teng, Foley, O’Neill, & Hicks, 2014).  
Thus, the ability of passive shipping containers to maintain product temperature 
correlates with the design of the container, the type of refrigerant, transit time, and 
external temperatures. 
CCSSs help maintain product temperatures, but the effectiveness of CCSSs is not 
easily measured (Joshi et al., 2012).  SCM practitioners can improve their cold chains by 
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collecting performance data on shipping solutions to identify gaps and weaknesses in 
their processes (Joshi et al., 2012).  These gaps and weakness correlate to the lack of 
CCM standards for CCSSs used to mitigate extreme heat and cold during transit.  
Hidestrand et al. (2012) defined extreme cold is any temperature lower than 0 °C, and 
extreme heat is any temperature higher than 35 °C.  Temperature extremes can affect the 
performance and quality of perishables (Joshi et al., 2012). 
SCM practitioners can use information technology (IT) to track temperature 
excursions.  The e3-control redesign methodology is an IT-enabled data collector, 
capable of both real-time temperature monitoring and global positioning (Liu et al., 
2012).  SCM practitioners can use IT to inform themselves of a problem, which gives 
SCM practitioners the ability to stabilize the shipment through re-icing or active 
refrigeration. 
Organizational and Educational Requirements in the Medical Device Industry 
SCM executives in the medical device industry could inadvertently cause harm to 
patients by failing to train their SCM practitioners in CCM from a regulatory and 
shipping perspective.  Educated and experienced SCM practitioner have a working 
knowledge of the regulatory requirements needed to ship temperature-sensitive products 
globally from a storage and transportation perspective (Lis et al., 2009).  These SCM 
practitioners are familiar with the International Air Transport Association regulations that 
govern packaging and labeling of DMDs (Lis et al., 2009).  Knowledgeable SCM 
practitioners use CCSSs designed to maintain specific temperature ranges during transit 
(Lis et al., 2009).  Properly selected shipping solutions ensure temperature-sensitive 
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products have fewer temperature excursions when shipped to hospitals and physicians’ 
offices. 
Medical device failures caused by temperature excursions could result in the 
misdiagnosis of a patient.  To prevent these failures, SCM practitioners need advanced 
information systems and software to identify substandard supply chain performance and 
monitor expensive cold chain inventories (Zaffran et al., 2013).  The utilization of supply 
chain technology requires well-trained SCM practitioners.  Zaffran et al. (2013) 
suggested that hiring entities in developing countries should target professionally trained 
SCM managers.  Ultimately, management is responsible for hiring employees into 
functional areas of the organization.  Likewise, management hierarchy exists to allocate 
resources, including tools and education, necessary to help employees achieve 
performance standards (Zaffran et al., 2013).  Thus, SCM executives must hire 
professionally trained SCM practitioners who can achieve organizational performance 
standards through the right technology to maintain all aspects of the cold chain. 
SCM practitioners with CCM competency are invaluable to organizations that 
ship temperature-sensitive medical devices.  The lack of CCM competency was a factor 
in how workers handled temperature-sensitive vaccines in India (Rao, Naftar, Baliga, & 
Unnikrishnana, 2012).  Workers in India failed to store temperature-sensitive vaccines 
properly 10% of the time (Rao et al., 2012).  The proper storage of temperature-sensitive 
vaccines is critical to the effectiveness of vaccines used in controlling preventable 
diseases.  The gap associated with the improper storage of vaccines requires additional 
training in CCM (Rao et al., 2012). 
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SCM executives who are responsible for shipping temperature-sensitive products 
have some level of competency in CCM.  Sharing of competency throughout the 
organization improves performance (da Silva Gonçalves Zangiski, de Lima, & da Costa, 
2013).  Therefore, SCM executives with specific CCM objectives are more likely to drive 
organizational learning to improve performance.  Organizational learning starts with an 
individual’s self-awareness into specific objectives (da Silva Gonçalves Zangiski et al., 
2013).  In consequence, there is a direct correlation between a leader’s awareness and his 
or her action or inaction, which fits with the theory of the SCA model.  Ultimately, SCM 
executives are responsible for CCM innovation within their organizations. 
Regulatory Requirements for Distribution  
SCM practitioners must be able to distribute DMD tests and controls while 
meeting regulatory and stability requirements.  The FDA requires medical device 
manufacturers to ensure proper storage and distribution of DMD tests and controls (FDA, 
2011).  Storage and distribution requirements may vary for temperature-sensitive DMD 
tests and controls.  For example, DMD test and controls may require ambient, cold, 
frozen, and ultra-low (cryogenic) temperatures for storage and distribution.  Neri et al. 
(2013) explained that ambient shipping with long lead times and exposure to extreme 
heat could cause temperature-sensitive products to have false high readings.  Therefore, 
temperature-controlled infrastructure and shipping solutions are required for compliant 
distribution of medical devices in warmer regions (Albertini et al., 2012).  SCM 
practitioners who fail to use CCSSs for ambient or control room temperature products 
have higher frequencies of temperature excursions. 
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Temperature-sensitive diagnostic tests that use reagents and quality control panels 
require CCM (Palamountain et al., 2012).  However, there are challenges associated with 
effective CCM, such as the lack of SCM expertise, product traceability, and poor health 
care infrastructure (Palamountain et al., 2012).  These challenges can adversely affect the 
quality of DMD tests and controls (Palamountain et al., 2012).  For example, inadequate 
infrastructure, transportation, training, and quality can undermine clinicians’ ability to 
perform effective laboratory screening (Pruett et al., 2014). 
In many countries, the lack of quality control in the supply chain has led to 
clinicians distrusting the precision of DMDs from a test results perspective 
(Palamountain et al., 2012).  Maltha et al. (2013) asserted that diagnostic tests lacked 
information regarding the required storage temperatures on the outer packaging and the 
instructions for use.  The lack of quality control may require regulatory agencies to 
increase their governance over the medical device industry.  Strengthening of regulatory 
governance would encourage SCM executives to make improvements to their SCM 
practices (Palamountain et al., 2012), such as through the attachment of temperature 
control monitoring tags in a CCSS to indicate temperature excursions during transit 
(Maltha et al., 2013).  End users might need training on how to manage temperature-
sensitive products that arrive at their hospitals, laboratories, and physician offices 
(Maltha et al., 2013). 
Developing countries struggle with the adoption of modern diagnostic 
technologies because of limited access to diagnostic laboratories, poorly trained health 
care workers, insufficient quality systems, and inadequate SCM capabilities (Mabey et 
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al., 2012).  These modern diagnostic tests can use either blood from a finger prick or 
urine to generate test results (Singh et al., 2013).  For example, there are diagnostic 
devices that use enzyme-linked immunosorbent assays, indirect immunofluorescent 
antibody tests, and direct agglutination tests that require CCM from the factory to the 
clinician (Singh et al., 2013).  In addition, there is a functional difference between a 
diagnostic test and a rapid diagnostic test. 
Laboratories run diagnostic tests on large analyzers while rapid diagnostic tests 
provide results within minutes in an environment that has minimal infrastructure 
(Yansouni et al., 2013).  For example, GeneXpert and Abbott manufacture a test that 
helps in the diagnosis of trachoma, which is a preventable disease that causes blindness 
(Dize et al., 2013).  Test specimens for trachoma were collected in Tanzania and shipped 
to the United States for analysis at Johns Hopkins University (Dize et al., 2013).  SCM 
practitioners for Johns Hopkins University required frozen transit and the utilization of –
80 °C storage (Dize et al., 2013).  Complicated global shipments require SCM 
practitioners who are knowledgeable about CCM strategies.  Cognitive mapping can 
identify SCM executives’ knowledge of CCM strategies. 
Cognitive Mapping 
Leaders require various types of data to make decisions (Grӧtsch, Blome, & 
Schleper, 2013).  Consequently, the cognitive rationalization of various types of data 
influences a leader’s decision making (Grӧtsch et al., 2013).  The fourth theme in the 
literature review is cognitive mapping as a tool used to gather unique insights into the 
how and why leaders make decisions that positively and or negatively influence their 
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organizations.  In this section, I offer and contrast several mapping variants as a tool used 
in conducting this study. 
Overview of cognitive mapping.  Tolman (1948) introduced the concept of 
cognitive maps in a comparative analysis of rats and the clinical behaviors of human 
beings.  The study drew a stark comparison between the natural tendencies of rats to 
those of human beings.  Tolman established that rats and human beings have three 
dynamics in common: regression, fixation, and displacement.  Regression leads to 
individuals’ inability to cope with difficult situations, causing individuals to revert and to 
act in childish ways. Fixation leads to a strong focus on learned behaviors, making 
change difficult.  Displacement of aggression onto other groups leads to individuals 
strictly aligning their goals, life, and immorality to those of the group while shunning all 
other groups.  Consequently, Tolman warned that society should make every effort to 
prevent discriminatory behaviors among the races.  Tolman’s research led to various 
other cognitive map-based studies in the areas of psychology, education, urban planning, 
history, business, and management. 
Ackerman et al. (1992) traced the technique of cognitive mapping to 1955 and 
Kelly's theory of personal constructs.  Winter (2013) explained that the construct theory 
establishes that individuals actively construct their world.  Therefore, researchers can use 
the construct theory to better understanding how individuals view the world (Ackermann 
et al., 1992).  Constructs support a mixed-methods approach to research, making 
construct theory suitable for both quantitative and qualitative analysis (Winter, 2013).  
The use of cognitive mapping helps unravel constructs into meaningful insight. 
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Cognitive mapping is a key technique used by consultants to develop corporate 
strategy.  Consultants use cognitive maps in live interviews to explore the decision 
maker’s thought process for key strategies.  Cognitive mapping is a versatile approach to 
operational research; it allows the researcher to understand the phenomenon from the 
interviewee’s perspective (Ackermann et al., 1992).  According to Ackermann et al. 
(1992), a researcher achieves insight into the phenomenon when he or she generates 
cognitive maps that are graphical representations of the interviewee’s thoughts regarding 
a particular phenomenon.  Researchers can use these maps to structure, organize, and 
analyze the interviewee’s perspective of the phenomenon (Ackermann et al., 1992).  The 
participative nature of cognitive mapping makes interviewees participants. 
Participants who are decision makers may have direct influence over the activities 
of their respective organization (Grӧtsch et al., 2013).  For the present study, I made sure 
participants had a direct influence on the phenomenon within their respective 
organization.  Therefore, the cognitive maps generated by participants may lead to new 
knowledge or insights into a phenomenon, which may improve business practices or 
provide a better understanding of business decisions. 
Mapping variants.  I used Decision Explorer, a software product, to create 
different mapping variants.  The three types of mapping variants are mind mapping, 
concept mapping, and cognitive mapping.  I used Decision Explorer to explore each 
mapping variant to determine the most fitting mapping technique to conduct this study.   
The first mapping variant explored was mind mapping.  Mind mapping is a tool 
for exploring the central idea.  Decision Explorer generates mind maps as a form of 
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brainstorming.  Using Decision Explorer, I constructed a mind map and connected all of 
the associated variables surrounding my central idea.  The identified outcomes of mind 
maps rendered this mapping variant unsuitable for conducting this study. 
The second mapping variant explored was concept mapping.  Concept mapping 
using Decision Explorer is similar to cognitive mapping.  Concept and cognitive maps 
have nodes and links to illustrate concepts and relationships (Jones, van Kessel, Swisher, 
Beckstead, & Edwards, 2014).  I used Decision Explorer to generate concept maps, 
which required the use of descriptive words for the nodes and relational labels for the 
links.  Wood, Bostrom, Bridges, and Linkov (2012) described concept mapping as nodes 
that represent concepts or key ideas and links that represent the relationships between the 
concepts or key ideas.  The identified outcomes of concept maps rendered this mapping 
variant unsuitable for conducting this study. 
The third mapping variant explored was cognitive mapping.  I used Decision 
Explorer to generate cognitive maps, which required the use of phrases for the nodes and 
directional labels for the links.  Wood et al. (2012) explained that nodes represent the key 
ideas, while links express the relationship to the nodes in the form of arrows to indicate 
influences.  The identified outcomes of cognitive maps rendered this mapping variant 
suitable for conducting this study.  The application and assessment of cognitive mapping 
vary among scholars (Jones et al., 2014).  Therefore, I explored the application of 
cognitive mapping for this study. 
Application of cognitive mapping.  The application of cognitive mapping in the 
areas of business and management is diverse.  For example, cognitive mapping can 
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improve navigation tools by understanding how participants react cognitively to various 
navigational outputs (Ooms, De Maeyer, Fack, Van Assche, & Witlox, 2012).  In 
addition, cognitive mapping has provided insight into how engineers perceive the 
strategic goals of management from an execution and obtainment perspective (Village, 
Salustri, & Neumann, 2013).  Cognitive mapping helps users to understand how to build 
and improve trust in business relationships (Huang & Wilkinson, 2013).  Additionally, 
cognitive mapping provides a comparative analysis of how marketing decisions may 
affect consumers (Usunier & Sbizzera, 2013). 
Cognitive mapping is a tool and method used to understand the phenomenon from 
a research perspective.  Buckley and Waring (2013) asserted that researchers could use 
mapping to capture multiple viewpoints when exploring a social phenomenon.  
Researchers use cognitive maps to probe deep into the nature of a phenomenon (Jones et 
al., 2014).  The cognitive exploration into the phenomenon generates large amounts of 
information.  I used Decision Explorer to manage, synthesize, and interrupt participants’ 
cognitive maps associated with the phenomenon. 
Cognitive mapping requires in-depth inquiry into the phenomenon, which could 
result in long interviews.  For example, Septer, Dijkstra, and Stokman (2012) conducted 
2-hour interviews when cognitively mapping participants.  The time commitments 
associated with cognitive mapping could negatively influence the number of participants 
willing to partake in a study (Jetter & Kok, 2014).  For example, Bostrom et al. (2015) 
solicited 100 interviewees through e-mail, but were only able to secure nine participants 
who shared a common interest and understanding of the phenomenon.  Participants with 
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competing interests in a shared phenomenon can negatively affect the reliability of a 
study (Wood et al., 2012).  Additionally, participants with overarching agendas can 
distort their recollections associated with the phenomenon (Jetter & Kok, 2014).  The 
usage concerns of cognitive mapping expand beyond the selection criteria for 
participants.  I address the various challenges associated with cognitive mapping in 
Section 2 of this study. 
Transition  
Section 1 of this study included the background, the problem, purpose, nature, 
conceptual framework, assumptions, limitations, delimitations, the significance of the 
research, and literature review.  The foundation of this study tied directly to the literature 
review.  I synthesized conceptual framework of six-change approaches model, historical 
overview of CCM, regulatory governance of medical devices, influences on CCM, 
CCSSs, organizational and educational requirements, product stability of tests and 
controls, and the application of cognitive maps from a research perspective in the 
literature review.  The foundation of this doctoral study also lends to the development of 
the research methodology.  In Section 2, I focused on the research methodology on the 
role of the researcher, participants, research method and design, population and sampling, 
ethical research considerations, data collection, data analysis technique, and reliability 
and validity of the doctoral study. 
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Section 2: The Project 
Section 2 includes the methodology used for conducting this doctoral study.  In 
this section, I revisit the purpose statement, explain my role as the primary data collection 
instrument, and review the participation requirements.  Next, I explain the research 
method and research design, clarify the sampling plan and population, and review the 
plan for ethical research.  I cover the data organization technique using Banxia Decision 
Explorer Version 3.3.2 and explain data analysis using cross-case synthesis to ensure 
reliability and validity.  Lastly, I describe how the data analysis procedures follow the 
same linear sequence of steps presented in Section 3. 
Purpose Statement 
The purpose of this qualitative multiple case study design was to explore medical 
device executives’ strategies for shipping temperature-sensitive DMD tests and controls.  
The target population consisted of SCM executives who work in the medical device 
industry.  The geographic locations for participants were California, New Jersey, and 
Ireland. 
Insight into the diversification or lack of standardization of CCSSs used by SCM 
executives in the medical device industry may contribute to CCM strategies, new 
knowledge, increased quality, and financial savings.  The identification of CCM 
strategies could fast-track SCM executives’ adoption of shipping solutions that mitigate 
temperature excursions that result in medical errors with patients.  SCM executives who 
adopt CCM strategies may promote social and economic benefits on a global scale by 
reducing the medical errors that cause patient harm and death. 
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Role of the Researcher 
I served as the primary data collection instrument in this qualitative multiple case 
study.  Peredaryenko and Krauss (2013) characterized researchers as the primary data 
collection instrument in facilitating in-depth interviews.  My objective as the primary 
data collection instrument was to provide a holistic account of the phenomenon of how 
and why DMD tests and controls lack standardized shipping strategies in the medical 
device industry.  Fusch and Ness (2015) suggested that researchers should take steps to 
mitigate personal views during data collection and analysis.  In this section, I account for 
(a) data collection, (b) associations with the phenomenon and participants, (c) personal 
bias mitigation, (d) ethical safeguards, and (e) rationale for the interview protocol.  The 
effective execution of my role as the primary data collection instrument gave me an 
unbiased opportunity to understand the strategies used by SCM executives in shipping 
temperature-sensitive DMD tests and controls. 
As the primary data collection instrument, I developed a trustworthy process for 
data collection.  Data collection procedures improve the trustworthiness of research 
findings (Power & Gendron, 2015).  The development of data collection procedures must 
occur before the presentation of case study findings (Hott, Limberg, Ohrt, & Schmit, 
2015).  Yin (2014) suggested that researchers should document the major tasks associated 
with the data collection procedures.  Purposive sampling is a method used to categorize 
and target potential participants within a population (Harvey, Marshall, Jordan, & Kitson, 
2015; Robinson, 2014).  My first major task was to purposively identify SCM executives 
working in the medical device industry from my professional network, send participants’ 
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an invitation letter, and formally evaluate participants eligibility to contribute to this 
doctoral study (see Appendix A and Appendix B).  Brédart et al. (2014) described 
informed consent as a process that seeks individuals’ participation while explaining the 
potential disadvantages, risks, and benefits associated with a study.  
My second major task was obtaining participant consent for a 2-hour online 
interview designed to generate real-time cognitive maps.  Baskarada (2014) explained 
that cross-case analysis is an iterative pattern-matching process that involves the use of 
case study data.  My third major task was rendering conclusions through pattern and 
theme analyses of cognitive maps, triangulations, and cross-case analysis.  Terrell (2012) 
noted that researchers must keep data confidential and available for an undisclosed 
amount of time.  My fourth major task was the safeguarding of research data and 
participant information for 5 years beyond the conclusion of the study.  Peredaryenko and 
Krauss (2013) found that researchers were susceptible to bias based on their personal 
experiences with the phenomenon.  I disclosed my experience and association with the 
phenomenon and participants to help mitigate personal bias. 
I am an SCM executive with more than 22 years of experience implementing 
across-the-board savings, innovation, and turnaround activities regarding people, process, 
systems, and infrastructure.  I have managed ambient and temperature-controlled 
distribution centers totaling 1.7 million square feet and transportation fleets up to 140 
trucks.  I am responsible for distribution, import and export, logistics, refrigerated storage 
and transportation, flexible manufacturing, postponement, reverse logistics, inventory 
management, warehousing, R&D of CCSSs, and dry ice manufacturing.  I have more 
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than 8 years of experience using CCM methodologies to ship and store DMDs in the 
medical device industry.  CCM is a controlled methodology for properly storing and 
distributing temperature-sensitive products (Reddy et al., 2012). 
Knowledgeable SCM practitioners use CCSSs designed to maintain specific 
temperature ranges during transit (Lis et al., 2009).  I developed validated CCSSs that 
incorporated the latest innovations regarding materials, durability, insulation, packing 
efficiencies, year-round usability, and shock absorption.  These validated CCSSs 
maintain DMD temperatures while mitigating flash freezing, excessive packaging, 
weight, and damage.  I also developed an extensive network of SCM executives who 
work in the medical device industry.  I purposively identified and selected participants 
from my network of SCM executives who have CCM experience in the medical device 
industry. 
The rendering of unbiased conclusions is paramount to documenting new business 
strategies and social change.  My direct knowledge and experience in CCM in the 
medical device industry could have caused me to introduce bias based on my personal 
experience of the phenomenon.  I took steps to mitigate personal bias.  Wolgemuth et al. 
(2014) advised that researchers should follow interview questions, accurately capture 
interview data, and validate captured interview data in real-time.  In response to that 
advice, I developed interview protocols that helped me to ask probing questions based on 
my personal experience and propositions while avoiding leading questions.  Baxter and 
Jack (2008) explained that researchers establish credibility by incorporating member 
checking into the data collection process, thereby validating the shared experiences of 
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participants.  The proper rendering of conclusions is an important criterion in conducting 
research.  I rendered conclusions based on the collected data and not my personal 
perceptions.   
Administrators at Walden University promote the highest ethical standards for 
doctoral research by having students seek approval from the institutional review board 
(IRB).  I ensured the humane and ethical treatment of participants through personal 
initiative and IRB review (see King, 2015).  Representatives of the IRB ensure that 
students of Walden University comply with all ethical standards and other applicable 
laws and regulations (Walden University, 2012).  All students attending Walden 
University must receive IRB approval before the collection or analysis of data (Walden 
University, 2012).  Administrators at Walden University also require students to take the 
National Institutes of Health web-based training course on protecting human research 
participants and following the standards of the Belmont report.  I completed this training 
on June 26, 2017 (Certificate Number 2424395).  Brakewood and Poldrack (2013) 
defined the standards of respect, justice, and beneficence in the Belmont report.  I met the 
standards of the Belmont report by (a) ensuring ethical data collection, (b) obtaining 
informed consent, (c) maintaining participant confidentiality, (d) preventing harm, and 
(e) ensuring equitable participant selection (see Yin, 2014). 
Participants 
I selected participants who could provide insights into the strategies used to ship 
temperature-sensitive DMD tests and controls.  The selection of participants requires 
great care and rigor (Noonan, 2015).  Properly selected participants are critical to 
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obtaining real-world insights into the phenomenon (Yin, 2014).  To ensure appropriate 
selection of participants, I developed strategies for participant eligibility, accessibility, 
and collaboration. 
The eligibility criteria for participants should coincide with the phenomenon 
under investigation.  Faulkner, Tremblay, and Latimer-Cheung (2014) noted that 
participatory eligibility of participants correlates to their familiarity with the phenomenon 
under investigation.  Greiner et al. (2015) explained that outlining the eligibility criteria 
ensures enrollment of appropriate participants.  Murphy, Hevey, O’Dea, Rathaille, and 
Mulcahy (2015) identified the need to define eligibility criteria for the selection of 
participants. 
I developed four eligibility criteria for this study.  First, participants must have 
worked in the medical device industry.  Second, participants must have had at least 5 
years of CCM experience.  Third, participants must have had national or global SCM 
responsibilities at the executive level.  Finally, participants were required to have 
influence over CCM strategies in their respective organizations. 
Addressing potential access limitations to participants was an important 
consideration for this study.  Friedman, Lulinski, and Rizzolo (2015) found that 
unidentified access limitation adversely influences research results.  Researchers should 
anticipate participant accessibility issues when determining a focus group (Savage, Moro, 
Boyden, Brown, & Kavanaugh, 2015).  Power and Gendron (2015) found that researchers 
improve participant access when they select informants from their personal network.  I 
used LinkedIn as a source for participants.  My LinkedIn network includes more than 
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1,230 professionals.  I narrowed my LinkedIn connection network to identify only SCM 
executives whom I had met during medical device conferences and forums over the past 
8 years.  I then purposively selected three SCM executives from my LinkedIn 
professional network who met the eligibility criteria.  My selection tactic increased 
access to participants, based on the large population size of my professional network.  As 
a result, a strategy for establishing a working relationship with participants was 
necessary. 
I established a working relationship with participants through frequent and open 
communications that were welcoming and considerate.  Deakin and Wakefield (2013) 
noted that researchers improve participant familiarity with a study through increased 
communications.  The initial communications with participants in the current study 
consisted of an invitation letter, participatory eligibility form, and consent form.  
Informed consent is as important as respectful interactions (Brédart et al., 2014).  My 
collaboration with participants included respecting their professional and personal time.  
Increased collaboration improves trust (Huang & Wilkinson, 2013).  Kaczynski et al. 
(2014) found that gaining trust from a participant takes time.  I maintained a professional 
working relationship with participants for the duration of the study. 
Research Method and Design  
I constructed the study by identifying the most fitting research method and design.  
The research methods considered for this study were quantitative, qualitative, and mixed-
methods.  The qualitative paradigm led to the consideration of the following qualitative 
research designs for collecting data: (a) narrative, (b) ethnographic, (c) 
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phenomenological, and (d) case study.  From these choices, I determined that the multiple 
case study was the most appropriate design. 
Research Method 
I initially considered quantitative research as the paradigm to answer my research 
question of what strategies SCM executives use to ship temperature-sensitive DMD tests 
and controls.  Terrell (2012) noted that quantitative research is the longstanding mainstay 
of the social sciences.  Yilmaz (2013) defined quantitative research as a method used by 
researchers to gain an understanding of a phenomenon through statistical analysis.  
Statistical analysis involves examining variables to explain, fit, or predict another 
variable rather than to explore the various dimensions of a phenomenon.  Fassinger and 
Morrow (2013) used quantitative methodology with large representative samples.  
Researchers typically ask a large number of participants a set of closed survey questions 
when performing quantitative studies (Brédart et al., 2014). 
I then considered qualitative research as a method to answer my research 
question.  Terrell (2012) used qualitative research to understand a phenomenon from a 
how or why perspective.  Astalin (2013) defined qualitative research as a method used to 
construct a holistic and narrative view of a social or cultural phenomenon based on a 
researcher’s observations, interviews, and review of documents.  In conducting a study 
using a qualitative method, researchers ask participants in-depth and open-ended 
interview questions (Brédart et al., 2014). 
I also considered mixed-methods to answer my research question.  Thamhain 
(2014) explained that mixed-methods research includes both quantitative and qualitative 
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methods to investigate a phenomenon.  Researchers approach the phenomenon with a 
quantitative perspective that is rational and a qualitative perspective that is intuitive 
(Thamhain, 2014).  Cox (2012) found that researchers performing mixed-methods studies 
would incorporate the qualitative research components into a more dominant quantitative 
framework. 
Having an in-depth understanding of each research method helped me choose the 
most fitting method.  The appropriate application of a research method to a study is 
contingent on the researcher’s knowledge of quantitative, qualitative, and mixed-methods 
research (Fassinger & Morrow, 2013).  Researchers should consider the phenomenon, as 
well as the data collection and analysis methods when choosing a research method 
(Allwood, 2012).  I rejected quantitative methodology based on the uniqueness of the 
nature of my study, including a small sample size, intrinsic data, and open-ended 
interview questions.  I also rejected a mixed-methods approach because this method 
requires both quantitative and qualitative data. 
I found the qualitative research method more fitting than the quantitative research 
method or mixed-methods.  Halkier (2013) and Wolgemuth et al. (2014) noted the 
qualitative research method affords researchers a high degree of control and flexibility in 
constructing studies.  Consequently, the analysis and synthesis of rich data may lead to 
new learnings, which could influence policies and or business practices.  Yin (2014) 
asserted researchers obtain new knowledge when they use a qualitative method.  Any 
new knowledge from this case study might apply to the medical device industry and the 
CCM bodies of knowledge. 
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Research Design 
The qualitative research designs considered were narrative, ethnography, 
phenomenological, and case study.  The initial constraint of the research design began 
with a baseline understanding of narrative and ethnography design.  I conducted a 
literature review to understand the narrative and ethnography research designs. 
Narrative research is a research design that primarily uses transcripts and 
interviews to explore the phenomenon (Smyth & McInerney, 2013).  McClelland et al. 
(2015) concluded that narrative research is useful for understanding the lived experiences 
of participants.  Fassinger and Morrow (2013) noted scholars are skeptical of narrative 
data that lack validity.  I excluded narrative research based on the literature review and 
the phenomenon of interest. 
Ethnography research is a research design used to interpret the social and cultural 
context of the phenomenon within the environment of occurrence (Astalin, 2013).  
Ethnography design requires the researcher to speak directly to participants, reflect, and 
draw a comparison to the larger community (Wolgemuth et al., 2014).  Smyth and 
McInerney (2013) used ethnography to explore the lived experiences and viewpoints of 
disadvantaged young people.  I excluded ethnography research based on the literature 
review and the phenomenon of interest. 
Having an in-depth understanding of each research design helped me constrain 
the study to the most fitting research design.  Baskarada (2014) explained the research 
design must include a means for evaluating the phenomenon.  I constrained the research 
design choice by using cognitive mapping as my primary technique to explore the 
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phenomenon.  Ackermann et al. (1992) remarked that consultants develop a corporate 
strategy by using cognitive mapping.  Consultants use cognitive maps in live interviews 
to explore a decision maker’s thought process by asking how and why questions.  Village 
et al. (2013) noted researchers use cognitive maps to explain how participants gain 
knowledge.  The use of cognitive mapping helped me to narrow the research design to 
phenomenological and case study. 
The phenomenological design is a research design used to understand the lived 
experiences of individuals who share a common phenomenon (Wolgemuth et al., 2014).  
Researchers use phenomenological research to survey data and draw conclusions from 
the lived experiences of participants, which is ineffective for the real-time validating of 
cognitive views (Ackermann et al., 1992; Wolgemuth et al., 2014).  Astalin (2013) 
concluded that researchers using phenomenological research design would generate 
awareness and not an in-depth understanding of the phenomenon.  As a result of having 
conducted a review of the literature on this design method, I was able to narrow the 
research design to a case study. 
Case study design is a research design used to study a recent phenomenon of 
interest within the environment of occurrence (Yin, 2014).  The research design of case 
study is an excellent framework for exploring health and social sciences to improve the 
human condition (Baxter & Jack, 2008; Halkier, 2013; Wolgemuth et al., 2014).  Yin 
(2014) explained that researchers use case study design to explore a phenomenon to add 
new learning.  The selection of cases study design still required additional constraint. 
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I considered single case study and multiple case study designs based on a 
contemporary phenomenon.  Single case study designs are typically less rigorous than 
multiple case study designs (Yin, 2014).  Goffin, Raja, Claes, Szwejczewski, and 
Martinez (2012) asserted that methodological rigor is critical to qualitative research.  A 
single case study is an investigation of a phenomenon based on a single case while a 
multiple case study is an investigation of a phenomenon occurring in multiple cases (Yin, 
2014).  Furthermore, case studies with one case are less rigorous than case studies with 
multiple cases.  As a result of this distinguisher, I was able to narrow the case study 
design to a multiple case study. 
Multiple case study is a research design used to provide a holistic understanding 
of how and why contemporary events occur through in-depth analysis (Yin, 2014).  A 
multiple case study is an investigation of a phenomenon occurring in multiple cases.  The 
purpose of this multiple case study design was to explore and synthesize a contemporary 
phenomenon occurring in the medical device industry.  Applying a multiple case study 
design enabled me to obtain a deeper understanding of the shared experiences of 
participants, in each organization, through Skype interviews (Wolgemuth et al., 2014).   
I used a multiple case study design to achieve data saturation through the number 
of cases analyzed.  More specifically, I achieved data saturation by selecting and 
interviewing three SCM executives, familiar with the phenomenon, as independent case 
studies for their respective organization.  McClelland et al. (2015) explained that data 
saturation occurs when three participants have closely aligned experiences to the 
phenomenon in a qualitative case study.  Furthermore, participants are more likely to 
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reflect on their day-to-day decisions and experiences in a multiple case study design 
(Wolgemuth et al., 2014).  Klassen and Vereecke (2012) retrospectively achieved data 
saturation after interviewing three to four managers in a multiple case study.  Researchers 
use interviews to achieve data saturation (Fusch & Ness, 2015).  Consequently, I asked 
qualified participants in-depth questions and followed up with member checking. 
According to Yin (2014), multiple case studies are less susceptible to criticism 
than a single case study.  For example, Klassen and Vereecke (2012) retrospectively 
obtained data saturation after interviewing three to four managers in a multiple case 
study.  The application of cognitive mapping across individual participants helped me 
generalize the strategies across all participants.  Therefore, a multiple case study design 
was fitting for this research. 
I applied the typology for a case study to support my overall research design (see 
Figure 4).  G. Thomas and Myers (2015) asserted that researchers use a case study to 
explore a subject of interest.  I selected a key case as the subject of the study.  G. Thomas 
and Myers (2015) claimed that a key case is a subject matter or topic that is of inherent 
interest to the researcher.  The objective of this case study was CCSSs.  The objective 
constitutes the analytical frame within the case (Thomas & Myers, 2015). 
I selected an exploratory approach as the purpose for the study.  The purpose of 
the study was to explore existing strategies and perhaps to identify or seek desirable 
strategies (Thomas & Myers, 2015).  G. Thomas and Myers (2015) suggested a 
researcher's approach to conducting a case study influences the importance of the theory 
associated with the study.  I selected theory building as the approach for the study.  The 
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approach to the study may help identify the best CCM strategies for executives working 
in the medical device industry. 
I selected multiple case study as the methodological choice for the study.  G. 
Thomas and Myers (2015) remarked that researchers must choose between single and 
multiple case study as the methodological choice.  The process supports the interviewing 
of multiple subjects separately (Thomas & Myers, 2015).  I chose multiple parallels as 
the process for the study.  Multiple case study design was fitting for this study because I 
was able to explore a specific case of interest and gain new insights into CCSSs. 
G. Thomas and Myers (2015) remarked that researchers use a case study to 
explore a subject of interest.  I was able to identify new CCM strategies and advance 
these strategies within the medical device industry.  Yin (2014) proposed researchers use 
theory building to explore theories and propositions.  I used the theory established in the 
SCA model by conducting interviews with executives who worked in the medical device 
industry. 
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Figure 4. A typology of case study.  Reprinted from The Anatomy of the Case Study, by 
G. Thomas and K. Myers, 2015, p. 64.  Copyright 2015 by G. Thomas & K. Myers. 
Reprinted with permission (see Appendix C). 
Population and Sampling 
In this multiple case study, the population was SCM executives who worked for 
global medical device companies and met the defined eligibility criteria.  The geographic 
locations for participants were California, New Jersey, and Ireland.  Poulis, Poulis, and 
Plakoyiannaki (2013) advised researchers to consider the population that is most capable 
of providing insight into the research question designed to explore a phenomenon of 
interest.  Olsen, Orr, Bell, and Stuart (2012) suggested researchers could achieve external 
validity when the targeted population determines the participating company.  The 
population came from three medical device companies, which could include subsidiaries.  
The population had life history homogeneity in the cognitive connections to the 
phenomenon, regardless of proximity (Robinson, 2014).  Therefore, the sample frame 
was SCM executives who oversee CCM and cold chain strategies in the medical device 
industry. 
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I selected purposive sampling on the assumption that voluntary participants were 
knowledgeable and more truthful than participants who do not have a rich understanding 
of the phenomenon.  I also considered the study was representative of a niche within the 
medical device industry, which made only uniquely qualified executives capable of 
addressing my overarching research question.  As a result, I purposively selected three 
SCM executives from my LinkedIn professional network who met the criteria of the 
population and sample frame. 
Using a purposive sampling strategy is appropriate for a qualitative multiple case 
study design (Baxter & Jack, 2008).  Yilmaz (2013) concluded that purposive sampling is 
appropriate for conducting qualitative studies with a unique case or few participants.  For 
example, Jaros and Saberwal (2013) used purposive sampling as a means of targeting 
participants who had the first-hand experience with a shared phenomenon in a qualitative 
case study.  Purposive sampling is a method used to categorize and target potential 
participants within a population (Harvey et al., 2015; Robinson, 2014). 
I achieved data saturation from a sample size of three SCM executives.  I have 
illustrated the process of obtaining data saturation by coding each SCM executive as Case 
1, Case 2, and Case 3.  Data saturation occurs when three participants have closely 
aligned experiences to the phenomenon in a qualitative case study (McClelland et al., 
2015).  Morse (2015) indicated that saturation occurs when the scope and replication are 
rich in data.  Researchers can obtain scope that is comprehensive and in-depth through 
open-ended interviews (Morse, 2015).  Researchers use interviews to achieve data 
saturation (Fusch & Ness, 2015). 
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The literal replication of this case study required each of the three SCM 
executives to function as an independent holistic case study (Yin, 2014).  As stated 
previously, I coded each SCM executive as an independent case study, with each case 
study forming a cognitive map.  Thus, I achieved data saturation by combining the first 
cognitive map, Case 1, with the second cognitive map, Case 2, to form a single cognitive 
map of Case 1 and Case 2. 
Next, I incorporated the third cognitive map, Case 3, and reviewed for any 
potential changes.  The complete incorporation of the third cognitive map resulted in the 
final cognitive map for Case 1, Case 2, and Case 3.  Therefore, the sample size of three 
SCM executives as individual case studies was fitting, based on Yin's (2014) perception 
that multiple case studies are less susceptible to criticisms than a single case study.  The 
replication of this study also ensured each participant was familiar with the phenomenon 
(Morse, 2015).  Klassen and Vereecke (2012) retrospectively achieved data saturation 
after interviewing three to four managers in a multiple case study.  Lastly, researchers 
achieve data saturation through data triangulation (Fusch & Ness, 2015). 
In this section, I elaborate on criteria for participant selection based on the 
reviewed literature and the phenomenon of interest.  Jessiman (2013) targeted 
participants based on personal experience and the review of the literature.  The purposive 
sample size of three SCM executives correlated with their first-hand experiences with 
DMD tests and controls lacking standardized shipping practices in the medical device 
industry.  Purposive sampling is a method used to target potential participants within a 
population (Harvey et al., 2015; Robinson, 2014).  Jaros and Saberwal (2013) explained 
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that purposive sampling is effective for targeting participants with first-hand experience 
about a specific phenomenon.  Consequently, I selected SCM executives who had 5 years 
of CCM experience in the medical device industry. 
Defining the interview setting occurred before scheduling interviews with 
participants.  The interview setting for this study was online rather than in person, which 
gave flexibility to each participant regarding his or her physical setting.  Brédart et al. 
(2014) noted that data collection improves when participants feel safe and comfortable in 
the interview setting.  In addition, Janghorban, Roudsari, and Taghipour (2014) found 
that researchers could help key informants improve their interview setting through the 
utilization of Skype as a free online service for conducting real-time interviews.  I 
contacted each of the participants through an e-mail to determine a mutually convenient 
date and time for his or her online interview. 
Each online interview conducted via Skype lasted approximately 2 hours.  Akard, 
Wray, and Gilmer (2014) noted that web-based communication tools are effective for 
data collection.  For example, Skype is an effective real-time interviewing medium for 
conducting interviews that may range from 30 minutes to 2 hours (Nind, Wiles, Bengry-
Howell, & Crow, 2013).  I also contacted participants through e-mail 48 hours before 
their online interview to reconfirm the scheduled interview date and time.  My proactive 
follow-up with participants might have helped to eliminate any potential scheduling 
conflicts that could have jeopardized my ability to engage each participant for the full 2 
hours. 
71 
 
Ethical Research 
I obtained my IRB approval number 10-06-17-0352801 before conducting this 
study.  Akard et al. (2014) explained that IRB approval is an institutional requirement.  
IRB administrators ensure researchers meet ethical and regulatory standards (Cseko & 
Tremaine, 2013).  King (2015) noted that the IRB provides ethical guidance to 
researchers to protect the welfare of research participants.  Ethical research is a critical 
component in the overall process of protecting participants.  I covered the ethical 
mechanisms for protecting participants through informed consent, participant withdrawal, 
individual and organizational confidentiality, and data security. 
I protected human research participants by ensuring informed consent and 
explaining voluntary withdrawal.  Brédart et al. (2014) outlined informed consent as a 
process through which the researcher seeks individuals’ participation while explaining 
the potential disadvantages, risks, and benefits associated with a study.  Janghorban et al. 
(2014) concluded that researchers could obtain informed consent online or through e-
mail.  Failure to obtain informed consent could result in participant harm (King, 2015).   
I obtained informed consent by sending participants an e-mail explaining the 
ethical research process and having them sign my IRB-approved consent form.  Brédart 
et al. (2014) outlined voluntary withdrawal as a right that participants have to end their 
participation in a study.  Janghorban et al. (2014) expressed that participants who 
experience uneasiness during an online interview could withdraw with a push of a button.  
I ensured all participants were aware that their participation in this study was voluntary 
and that they could withdraw at any time from the study for any reason whatsoever. 
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I purposively selected participants who wanted to provide free insights into CCM 
strategies.  Cseko and Tremaine (2013) explained that researchers should justify 
compensation when the research may pose a minimal risk to participants.  Hadidi, 
Lindquist, Treat-Jacobson, and Swanson (2013) found that compensation did not 
adequately account for participants’ time in a study.  Jessiman (2013) suggested thanking 
participants and sharing results as a substitution to compensations.  Therefore, 
participants did not receive monetary compensation for their participation in this study.  
However, I thanked participants and committed to sharing the published doctoral study in 
recognition of their contributions. 
The process of collecting data required me to protect the privacy of participants 
and confidential data.  Cseko and Tremaine (2013) concluded that researchers are 
responsible for protecting the privacy of participants while keeping data confidential.  I 
protected the identity of each participant and their employer by coding their identities.  I 
also coded participants and their employer as Case 1, Case 2, and Case 3, followed by the 
participant’s geographical area of responsibility, as shown in Table 4.  Brakewood and 
Poldrack (2013) noted that researchers must have effective database security to maintain 
confidentiality.  I maintained electronic data on a password-protected computer and 
physical data in a locked, tamper-proof, and fire-resistant safe throughout the study 
period.  Terrell (2012) noted that researchers must keep data confidential and available 
for an undisclosed amount of time.  I will ensure electronic and physical data undergoes 
destruction 5 years from the publication date of this study. 
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Table 4 
Confidential Coding for Each Participant and Employer 
 
Participant and employer 
 
Geographical responsibility 
Interview questions and 
answers 
Case 1 TBD 0001–0999 
Case 2 TBD 1000–1999 
Case 3 TBD 2000–2999 
Data Collection Instruments 
I served as the primary data collection instrument in this qualitative multiple case 
study.  Kaczynski et al. (2014) remarked that researchers are the human instrument in 
qualitative studies, based on their data collection methodology and analysis.  
Peredaryenko and Krauss (2013) theorized that human instruments that were researcher-
centered would take a methodical approach to data collection, based on their existing 
knowledge of the phenomenon.  Peredaryenko and Krauss classified researchers as the 
primary data collection instrument.  As the primary data collection instrument, I 
collected, organized, and analyzed in-depth interviews with the aid of Decision Explorer.   
I conducted in-depth interviews in real-time using a semistructured approach and 
posing open-ended interview questions.  Interviews took place online and utilized video 
conferencing by Skype.  Yin (2014) asserted that prolonged case study interviews are 
effective in gaining a rich and in-depth understanding of the nature of the phenomenon.  
Yin (2014) suggested that researchers using a semistructured approach and open-ended 
interview questions should adopt a conversational tone with informants.  Yilmaz (2013) 
defined posing open-ended interview questions as an unbiased means for researchers to 
gain an understanding of participants’ experiences.  Wolgemuth et al. (2014) 
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recommended that researchers should follow interview questions, accurately capture 
interview data, and to validate captured interview data in real-time.  Therefore, I recorded 
each online interview should future data verification be required. 
I could also have collected secondary sources of data.  Yin (2014) stated that 
secondary sources of data help researchers corroborate multiple sources of information.  
The collection of secondary sources of data such as company information affirms or 
refutes primary data through triangulation.  Stanger et al. (2012) explained researchers 
triangulate multiple sources of data to understand the phenomenon without bias.  
Kaczynski et al. (2014) determined that researchers who triangulate data sources improve 
the rigor and creditability of their study.  Therefore, I triangulated primary data inputted 
into Decision Explorer with secondary data made available by participants. 
Decision Explorer is a data analysis instrument (Ackermann et al., 1992).  I 
purchased Decision Explorer from Banxia to obtain software usage rights.  I attached a 
copy of my receipt that indicates my purchase of Decision Explorer (see Appendix D).  I 
presented data entered into Decision Explorer in the appendices, as indicated in Section 3 
of this study.  Baskarada (2014) noted that researchers are responsible for performing the 
research procedures associated with collecting data.  Peredaryenko and Krauss (2013) 
asserted researchers are the primary data collection instrument.  Hence, it was my 
responsibility to collect and input data directly into Decision Explorer.  As a result, I did 
not need to provide software usage training to participants or to make adjustments or 
revisions to the functionality of Decision Explorer. 
75 
 
I inputted real-time interview data into Decision Explorer.  I then used Decision 
Explorer to construct cognitive maps based on my real-time collaboration with 
participants.  These cognitive maps are in the appendices.  Septer et al. (2012) established 
that cognitive maps could capture a participant’s rationale, which in turn provides insight 
into the participant’s decision-making process.  Ackermann et al. (1992) remarked that 
researchers could use Decision Explorer to understand the phenomenon from the 
interviewee’s perspective.  Researchers can then structure, organize, and analyze each 
interviewee’s perspective on the phenomenon (Ackermann et al., 1992). 
I used the collaborative functionality of Decision Explorer to improve the validity 
of collected data.  Brédart et al. (2014) achieved validity by performing in-depth 
interviews that elicited patients’ experiences.  I obtained validity by giving participants 
an opportunity to member check the real-time construction of cognitive maps.  Houghton, 
Casey, Shaw, and Murphy (2013) defined member checking as an acknowledgment from 
participants that the transcriptions of their interview are accurate.  I entered real-time 
interview responses into Decision Explorer and gave participants the opportunity to 
acknowledge the accuracy of my inputs through member checking.  Baxter and Jack 
(2008) reported that researchers establish credibility by incorporating member checking 
into the data collection process, thereby validating the shared experiences of participants 
in real-time.  The use of an in-depth interview improved the reliability of the study from a 
consistency perspective. 
Furthermore, I ensured reliability by using Decision Explorer as a database and by 
recording interviews.  Baxter and Jack (2008) concluded that databases and recordings 
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improve the reliability of case studies by giving researchers the ability organize, store, 
search, and retrieve collected data.  For example, a recording of a member-checked 
interview gave me the ability to reconstruct a cognitive map previously generated in 
Decision Explorer.  I reconstructed a cognitive map by inputting recorded data from an 
interview into Decision Explorer.  I used a transcriber from TranscriptionPuppy.com to 
transcribe my interviews.  Lastly, I obtained a signed confidentiality agreement from the 
transcriber who worked for TranscriptionPuppy.com before utilizing the transcription 
services (see Appendix E). 
Triangulations of scholarly works function as converging lines of inquiry to the 
cognitive data obtained in each case study (Yin, 2014).  Yin (2014) determined 
researchers achieve reliability by performing an individual case question and answer 
process on the overarching research question, interview questions, and the theory that 
supported the conceptual framework for this study.  Yin (2014) asserted that the question 
and answer process gives readers the ability to perform cross-case analysis on the data 
collected in a study.  The analytical technique of cross-case synthesis may provide new 
understanding into the phenomenon of how and why DMD tests and controls lack 
standardized shipping practices in the medical device industry. 
I did not conduct a pilot test or study.  Yin (2014) defined a pilot study as an 
initial case study for determining research questions and the protocol.  Poulis et al. (2013) 
found that pilot studies help to determine the population.  For example, Bowden and 
Galindo-Gonzalez (2015) used a pilot study to target participants based on limited 
funding. 
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Data Collection Technique 
I used the data collection technique to provide a credible explanation on how and 
why SCM executives thoughtfully select, manage, and control the cold chain shipping of 
DMD tests and controls.  I also explained the advantages and disadvantages associated 
with the data collection technique.  Elo et al. (2014) suggested researchers improve the 
trustworthiness of a study by designing an effective data collection process.  Platt and 
Skowron (2013) found researchers gain interview consistency when they use an interview 
protocol. 
Fusch and Ness (2015) explained that data collection, coupled with the correct 
research design, increases the likelihood that a researcher will be able to answer his or her 
research question.  Elo et al. (2014) suggested purposive sampling could lack 
trustworthiness when the researcher fails to elaborate on the sampling method.  
Therefore, I ensured my data collection technique was consistent and provided insight 
into the overarching research question.  The overarching research question that directed 
this study was, “What are the strategies some medical devise executives use for shipping 
temperature-sensitive DMD tests and controls?” 
I conducted in-depth interviews via Skype.  Wolgemuth et al. (2014) found 
researchers could effectively use Skype to conduct in-depth interviews lasting 1 to 3 
hours.  In addition to the real-time interviews, participants either member-checked the 
real-time construction of their cognitive maps or I scheduled a follow-up meeting.  Baxter 
and Jack (2008) explained researchers establish credibility by incorporating member 
checking into the data collection process, thereby validating the shared experiences of 
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participants.  Furthermore, Wolgemuth et al. suggested that researchers should follow 
interview questions, accurately capture interview data, and validate captured interview 
data in real-time. 
I now elaborate on the disadvantages associated with the data collection 
technique.  Fusch and Ness (2015) explained that data collection is unique, which makes 
data saturation inconsistent between studies.  Moreover, defective data collection can 
adversely influence the trustworthiness of a study (Elo et al., 2014).  Wolgemuth et al. 
(2014) found that researchers who shared their experiences associated with the study 
provoked participants to be less forthcoming during the interview.  As a result, I followed 
my participant scheduling and online interview protocol (see Appendix F). 
A data collection technique begins with the scheduling of participants.  Granot, 
Brashear, and Cesar Motta (2012) remarked that participants are stakeholders in 
determining the interview schedule.  I collaborated with participants to determine the 
feasibility of an online interview via Skype.  Wolgemuth et al. (2014) found researchers 
could effectively use Skype to conduct in-depth interviews lasting 1 to 3 hours.  I 
determined a mutually acceptable date and time for a 2-hour online interview with each 
participant. 
Granot et al. (2012) noted researchers must determine if participants are willing 
and capable of using Skype as a means of conducting the interview.  Therefore, I 
confirmed each participant was familiar Skype and, if necessary, provided a link for 
participants to download Skype before their interview.  I also contacted the participants 
48 hours before their scheduled interview.  Finally, 24 hours before each scheduled 
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interview, I ensured all interviewing essentials, such as a laptop, Skype, and Decision 
Explorer were fully functional. 
I followed my interview protocol to conduct each of the three online interviews 
using Skype.  Condie (2012) explained that the interview protocol is a series of verbal 
prompts that researchers use to interview systematically.  I followed these steps to collect 
the interview data.  First, I asked an interview question, as outlined in the interview 
protocol.  Next, I recorded the participant’s response directly into Decision Explorer. 
Baxter and Jack (2008) asserted that member checking increases the credibility of 
a study by giving participants an opportunity to clarify and correct shared data.  I 
confirmed with the participants that I accurately captured their answers to my questions.  
I posed follow-up questions as needed.  The purpose of these follow-up questions was to 
gain an in-depth understanding of each interview response to each question, which 
corresponded to a specific proposition (Yin, 2014).  I then asked follow-up questions 
aligned to the proposition, such as how or why questions to obtain additional insight into 
the original answer and enter participant feedback into Decision Explorer.  Once again, I 
confirmed with the participants that I accurately captured their answers to my follow-up 
questions.  I followed this reiterative process for each interview question and performed 
real-time member checking until there were no new data. 
Data Organization Technique 
Data collected for this study included Skype interviews, electronic journals, 
company information, and supporting literature.  I organized the collected data on my 
computer with the aid of qualitative data analysis software.  Baxter and Jack (2008) 
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remarked that researchers could improve case study reliability by using computer-aided 
qualitative data analysis software for data collection and organization.  Baxter and Jack 
asserted that databases improve the reliability of case studies because databases provide 
researchers the ability to organize, store, search, and retrieve collected data.  Ackermann 
et al. (1992) suggested researchers could use Decision Explorer to structure, organize, 
and analyze each interviewee’s perspective on the phenomenon.  Therefore, data 
organization occurred directly within Decision Explorer, which is software designed for 
data collection, organization, and analysis. 
Because I collected the data, I was obliged to protect the privacy of participants 
and their confidential data.  Cseko and Tremaine (2013) asserted researchers are 
responsible for protecting the privacy of participants while keeping data confidential.  
Furthermore, Brakewood and Poldrack (2013) stated that researchers must have effective 
database security to maintain confidentiality. 
Terrell (2012) noted that researchers must keep data confidential and available for 
an undisclosed amount of time.  I will maintain electronic data on a password-protected 
computer and physical data in a locked, tamper-proof, and fire-resistant safe for 5 years.  
I will wait for 5 years from the publication date of this study before I destroy all 
electronic and physical data. 
Data Analysis 
I used data triangulation to analyze the data collected for and generated in this 
study.  Yin (2014) suggested that researchers should conduct data triangulation when 
they use multiple sources of data, such as documents, field notes, archival records, and 
81 
 
open-ended interviews to develop converging evidence that explains the phenomenon.  
Yin (2014) stated that secondary sources of data help researchers corroborate multiple 
sources of information.  Furthermore, the use of multiple sources of evidence improves 
the internal validity associated with case study research (Yin, 2014). 
Goffin et al. (2012) explained that researchers could increase internal validity by 
incorporating multiple sources of data in their study.  The collection of secondary sources 
of data such as company information could affirm or refute primary data through 
triangulation.  Stanger et al. (2012) recommended that researchers should triangulate 
multiple sources of data to understand the phenomenon without bias.  Kaczynski et al. 
(2014) asserted that triangulated data sources improve the rigor and creditability of a 
study. 
Chenail (2012) noted researchers who perform data collection must also perform 
data analysis.  As such, after having completed the data collection process, I began my 
analysis of the data by using Decision Explorer as a tool to view the data.  Ackermann et 
al. (1992) remarked that researchers use Decision Explorer to analyze large amounts of 
data collected during interviews.  Decision Explorer requires researchers to define how 
the instrument is utilized (Ackermann et al., 1992).  Ackermann et al. asserted 
researchers must use open-ended interview questions to construct cognitive maps. 
The interview questions are in Appendix G.  Yin (2014) suggested that prolonged 
case study interviews should be semistructured and involve open-ended interview 
questions to guide the conversation through a series of follow-up questions, such as how 
and why questions.  The purpose of posing follow-up questions was to gain an in-depth 
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understanding of participants’ responses to each interview question, which corresponded 
to a specific proposition (Yin, 2014). 
Decision Explorer is a software program that researchers can use to help identify 
themes and patterns associated with the phenomenon (Ackermann et al., 1992).  Yilmaz 
(2013) explained that researchers who perform proper data analysis could identify 
themes.  Yin (2014) proposed researchers use theory-building to explore theories and 
propositions.  I correlated key themes to the conceptual framework, propositions, and 
new literature supporting the study.  Baskarada (2014) suggested that researchers should 
use data analysis to correlate themes to theories and propositions. 
I used propositions to provide structure to the interview process.  I coded each 
proposition to specific interview questions to analyze the interview data stored in 
Decision Explorer, as shown in Appendix H.  Yin (2014) explained that researchers use 
propositions to provide structure in asking follow-up questions.  Propositions are broad 
statements that summarize the goals a study explores (Yin, 2014).  Ackermann et al. 
(1992) suggested that researchers list goals at the top of the cognitive map when they use 
Decision Explorer.  I demonstrated how to create a link between a proposition and 
interview question using Decision Explorer (see Figure 5). 
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Figure 5. Cognitive map illustrating an interview question linked to a proposition. 
I coded all interview data into Decision Explorer.  I numerically coded the 
propositions, interview questions, and interview answers in Decision Explorer for each 
case, as shown in Appendix I.  I also color-coded the text to help identify the data in each 
cognitive map generated in Decision Explorer.  The text was color-coded as follows: (a) 
propositions are black, (b) interview questions or goals are red, (c) interview answers or 
key issues are green, and (d) follow-up answers or supporting facts are black.  The last 
coding step is linking key issues and supporting facts to each goal.  Linkage coding 
enabled me to explore the consequences of a particular concept from a how and why 
perspective.  For example, how questions shown as downward arrows () between 
linked concepts and why questions shown as upward arrow () between linked concepts.  
The real-time coding of linked concepts provided me with additional insight into each 
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interview question.  I now demonstrate the entry of follow-up answers and the linkage to 
the first interview answer entered into Decision Explorer (see Figure 6). 
 
Figure 6. Cognitive map illustrating the entry and linkage of follow-up answers. 
The last step in the cognitive mapping process results in the creation of the final 
map.  Village et al. (2013) explained that researchers use cognitive maps to explain how 
participant obtain knowledge.  To create the final map, I addressed the analysis of data on 
answering the propositions associated with this study.  These propositions helped me to 
focus on and sort my data, which increases my likelihood of completing this study 
(Baxter & Jack, 2008).  To complete this study, I needed to create case-specific maps by 
analyzing and synthesizing answers to each interview question. 
Mullins and Soetanto (2013) found cognitive maps are a means to clarify issues 
and themes.  I triangulated the three individual case-specific maps to help identify key 
themes.  Then, I created a final map through cross-case synthesis.  Septer et al. (2012) 
concluded that cognitive maps could capture a participant’s rationale, which in turn 
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provides insight into his or her decision-making process.  Therefore, the final map may 
contribute to new knowledge or insights, increased quality, financial savings, and 
improved patient safety from a social change perspective in the medical device industry.  
I now illustrate how to consolidate two case studies into a final cognitive map using 
Decision Explorer (see Figure 7).  The cross-case analysis of all case studies into a final 
map helped me to gain insight into the goals and CCM strategies deployed by SCM 
executives in the medical device industry. 
 
 
Figure 7. Two cognitive maps consolidated into a final cognitive map. 
Reliability and Validity 
The incorporation of reliability and validity into the construct of this qualitative 
multiple case study was critical to establish its trustworthiness and credibility.  
Qualitative research achieves trustworthiness and quality by rigorously applying the 
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concepts of dependability, credibility, transferability, and confirmability as common 
themes throughout the study (Thomas & Magilvy, 2011).  Yin (2014) stated that 
reliability and validity are key criteria for judging the quality of a case study.  E. Thomas 
and Magilvy (2011) noted that reliability and validity are methods for establishing trust 
and confidence in qualitative research. 
Reliability 
The collection of dependable data is paramount to the reliability of qualitative 
research (Thomas & Magilvy, 2011).  Reliability allows an outside researcher to follow 
the protocols that guided a study and reach the same conclusions (Thomas & Magilvy, 
2011).  Protocols are operational steps that produce the same results when followed (Yin, 
2014).  The use of well-defined protocols can improve the dependability of a study by 
minimizing potential errors and personal biases (Yin, 2014).  To ensure dependability, I 
thoroughly documented the protocols used to construct and conduct this study. 
Validity 
Validity is a key attribute of scientific research (Brédart et al., 2014).  To ensure 
the validity of this qualitative study, I applied the concepts of credibility, confirmability, 
transferability, and data saturation.  I also demonstrated the validity of this study by 
reviewing the protocols used for member checking, triangulation, participant selection, 
and data collection and analysis. 
I established the credibility of this case study by conducting member checking, 
triangulation, and cross-case synthesis.  E. Thomas and Magilvy (2011) stated that 
qualitative research becomes credible when researchers ensure the representativeness of 
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all collected data.  Koelsch (2013) asserted that researchers achieve validity through 
member checking participants’ responses during interviews.  Therefore, I gave 
participants an opportunity to member-check their cognitive maps during the real-time 
construction of those maps to ensure the data were representative. 
Baxter and Jack (2008) asserted that member checking increases the credibility of 
a study by giving participants an opportunity to clarify and correct shared data.  This 
study has credibility because the interview data were member-checked and triangulated 
through the cross-case synthesis of each case (Yin, 2014).  The triangulation of multiple 
data sources helps researchers understand the phenomenon without bias (Stanger et al., 
2012).   
I also performed cross-case syntheses for each case.  Baskarada (2014) explained 
that researchers use cross-case analysis as an iterative pattern-matching process using 
case study data.  Researchers perform cross-case analysis in a multiple case study after 
analyzing each case (Derqui, Fayos, & Fernandez, 2016).  Researchers use cross-case 
analysis to obtain an in-depth understanding of the phenomenon (Derqui et al., 2016).  
Cross-case synthesis helped me understand how the research question, propositions, 
interview questions, and theory interrelate from a holistic view of the phenomenon (Yin, 
2014). 
E. Thomas & Magilvy (2011) indicated that confirmability is an achieved when a 
researcher establishes credibility, transferability, and dependability in a study.  Moreover, 
confirmability serves as an audit trail that outlines the decision made by a researcher 
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throughout the study (Houghton et al., 2013).  The audit trail justifies the rationale and 
methodological decision making of the researcher (Houghton et al., 2013). 
Goffin et al. (2012) stated that researchers achieve conformability when interview 
data represent a participant’s own words.  To ensure the confirmability of raw data, I 
developed an audit trail that clearly outlines interview questions, propositions used to 
guide this study, coding, and the utilization of Decision Explorer during the data analysis.  
I also achieved confirmability by maintaining all electronic and physical data collected 
during this study and will continue to do so for 5 years from the publication date of this 
study. 
Transferability is another important concept relevant to qualitative research.  
Transferability deepens the trustworthiness of a study (Thomas & Magilvy, 2011).  E. 
Thomas and Magilvy (2011) noted transferability occurs when a researcher provides an 
in-depth description of the population, demographics, and geographic boundaries used to 
conduct a study.  To improve transferability, I provided a rich description of the 
purposive sampling, identification, and screening of voluntary participants.  Purposive 
sampling is a method used to categorize and target potential participants within a 
population (Harvey et al., 2015; Robinson, 2014).  Jaros and Saberwal (2013) found 
purposive sampling is an effective means to target participants with first-hand experience 
about a specific phenomenon. 
I achieved data saturation by selecting and interviewing three SCM executives, 
familiar with the phenomenon, as independent case studies for their respective 
organization.  McClelland et al. (2015) explained that data saturation occurs when three 
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participants have closely aligned experiences to the phenomenon in a qualitative case 
study.  Klassen and Vereecke (2012) retrospectively achieved data saturation after 
interviewing three to four managers in a multiple case study.  Researchers use interviews 
to achieve data saturation (Fusch & Ness, 2015).  Consequently, I asked qualified 
participants in-depth questions and followed up with member checking.  I also reviewed 
multiples sources of data by conducting a comprehensive review of my interview notes 
and interview transcripts.   
Transition and Summary 
Section 2 of this study included a restatement of the purpose statement, followed 
by a discussion of the role of the researcher, participant selection process, research 
method and design, population and sampling, ethical research, data collection instrument, 
technique, and organization, data analysis, reliability, and validity.  Section 2 also 
included a discussion of the in-depth research strategy the researcher employed to 
achieve a greater understanding of the central phenomenon associated with the lack of 
standardization of CCSSs, which creates inconsistent practices in the distribution of 
DMD tests and controls in the medical device industry.  The research strategy and 
analysis supported the finding that may improve business practices while positively 
influencing social change.  Section 3 of this study includes the findings of this study, how 
these findings can influence professional practices, the implication of these finding for 
social change, recommendations for action and further research, and the overarching 
conclusion of the research. 
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Section 3: Application to Professional Practice and Implications for Change 
The objective of this qualitative study was to explore the strategies some medical 
device executives use for shipping temperature-sensitive diagnostic medical device 
(DMD) tests and controls.  Section 3 details the research findings, applications to 
professional practice, implications for social change, and recommendation for action and 
further study.  I present the strategies that medical device executive may use to ship 
temperature-sensitive DMD tests and controls.  This section closes with self-reflection 
and a conclusion. 
Introduction 
The purpose of this qualitative multiple case study was to explore the strategies 
medical device executives use for shipping temperature-sensitive DMD tests and 
controls.  The complexity of supply chain management (SCM) makes it difficult to 
identify with clarity the various interdependent strategies.  To achieve this goal, I used 
the qualitative research methodology to identify the strategies SCM executives deploy in 
the selection, management, and implementation of cold chain shipping solutions (CCSSs) 
in the medical device industry.  I recruited three SCM executives who work in the 
medical device industry in California, New Jersey, and Ireland.  Findings indicated how 
to develop valid CCSSs, gain regulatory compliance, and achieve cold chain management 
(CCM) for shipping temperature-sensitive DMD tests and controls. 
I collected, organized, and analyzed data to identify the strategies some medical 
device executives use for shipping temperature-sensitive DMD tests and controls.  
Ackermann et al. (1992) noted that researchers could identify corporate strategies using 
91 
 
Decision Explorer.  I applied the tool’s analytical workflow to develop and present the 
end-to-end strategies (see Figure 8).  First, I identified 386 distinct concepts using the 
central analysis functionality in Decision Explorer.  The central analysis focuses concepts 
on centrality to indicate how concepts influence the model.  Then, I consolidated the 
concepts into nine themes using the collapse analysis functionality in Decision Explorer.  
Collapse analysis focuses concepts with meta-links into specific themes chained to an 
argument.  Finally, I used pattern matching to group and synthesize the themes into three 
end-to-end strategies. 
 
Figure 8. Analytic workflow from concepts to strategies. 
The analysis of interview data in Decision Explorer revealed that 16 interview 
questions generated 386 distinct concepts, which led to the identification of three end-to-
end strategies, as shown in Table 5.  Nine themes emerged from the data analysis I 
conducted using Decision Explorer.  I synthesized these emerging themes into the 
following end-to-end strategies: (a) validating CCSSs, (b) compliant shipping of DMDs, 
and (c) CCM best practices. 
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Table 5 
Distinct Concepts Relating to the Three End-to-End Strategies of the Research Study 
Case Validating CCSSs 
Compliant shipping of 
DMDs 
CCM best practices 
C1 34 45 57 
C2 70 56 47 
C3 27 23 27 
Total 131 124 131 
Presentation of the Findings 
The overarching research question that guided this study was as follows: What are 
the strategies some medical device executives use for shipping temperature-sensitive 
DMD tests and controls?  I constructed in-depth interview questions to discover new 
facts and personal insights from SCM executives who participated in this study regarding 
the strategies used to ship temperature-sensitive DMD tests and controls.  Prolonged case 
study interviews involve the use of propositions to achieve a conversational tone with 
participants while ensuring alignment with the purpose of the study (Yin, 2014).  In the 
sections that follow, I discuss the three end-to-end strategies, the nine associated themes, 
the conceptual framework, and the propositions that supported the study. 
End-to-End Strategy 1: Validating Cold Chain Shipping Solutions 
The first end-to-end strategy indicated the importance of validating CCSSs to 
executives responsible for the compliant shipping of temperature-sensitive DMD tests 
and controls.  Three themes emerged from an analysis of the data, as shown in Table 6.  
The emerging themes were (a) third-party validation firms, (b) joint development of 
validation protocols, and (c) product labeling supports validation protocols, as shown in 
the final cognitive map (see Appendix J). 
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Table 6 
Themes Relating to the End-to-End Strategy of Validating CCSSs 
Case 
Third-party validations 
firms 
Joint development of 
validation protocols 
Product labeling 
supports validation 
protocols 
C1 20 26 23 
C2 22 25 22 
C3 23 23 35 
Total 65 74 80 
The theme of using third-party validation firms such as packaging manufacturers 
and packaging laboratories for the development of CCSSs was a concept emphasized by 
all three SCM executives in this study.  Third-party validation firms conduct temperature 
chamber testing to validate CCSSs.  Jadhav et al. (2009) explained that certified 
packaging laboratories use environmental chambers and temperature profiles to validate 
passive shipping containers. 
Another theme linked the joint development of validation protocols to third-party 
validation firms.  Validation protocols define the testing parameters for developing 
validated CCSSs.  Participants mentioned several validation protocols, such as transit 
times, internal product temperature, and external hot and cold temperature ranges in 
developing CCSSs that prevent temperature excursions when shipping DMD tests and 
controls.  Validated CCSSs help eliminate temperature excursions that occur during the 
shipping of temperature-sensitive products. 
The final theme identified in this end-to-end strategy was SCM executives’ 
assertion that validations protocols coincide with product labeling found on DMD tests 
and controls.  Agents for the FDA require passive shipping containers to have validation 
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protocols.  Consequently, DMDs have product labeling to indicate appropriate storage 
temperatures (Maltha et al., 2013). 
These themes revealed that SCM executives take a systematic approach to 
developing CCSSs.  However, data supported the proposition that CCSSs used in the 
medical device industry are validated, nonvalidated, or poorly validated, which may 
indicate a lack of standardization and inconsistent distribution strategies.  The lack of 
standardization may stem from the use of nonvalidated CCSSs for shipping older 
products.  Some SCM executives believe that nonvalidated CCSSs are appropriate for 
DMD tests and controls that have a complaint-free shipping history.  The lack of 
standardization and inconsistent distribution strategies support the conceptual framework 
used to develop the propositions that guided the study. 
I used the SCA model as the conceptual framework for this study.  Relevant 
propositions from the SCA model grounded the conceptual framework to the case study.  
The SCA model includes organizational change management strategies that SCM 
executives can use to standardize the CCSSs for shipping temperature-sensitive DMD 
tests and controls.  SCM executives who understand the underpinnings of the SCA model 
are more likely to identify misconceptions that may prevent the realization of new CCM 
strategies in their organization.  SCM executives should educate and align people with 
CCM strategies to prevent any misconceptions that may prevent change. 
End-to-End Strategy 2: Compliant Shipping of Diagnostic Medical Devices 
The second end-to-end strategy of the study linked the concept of compliance to 
the efficacy of temperature-sensitive DMD tests and controls.  Three themes emerged 
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from my data analysis, as shown in Table 7.  The emerging themes were (a) employee 
training, (b) auditing of business processes, and (c) the monitoring of DMD tests and 
controls, as shown in the final cognitive map (see Appendix K). 
Table 7 
Themes Relating to the End-to-End Strategy of Compliant Shipping of DMDs 
Case Employee training 
Auditing of business 
processes 
Monitoring of DMD tests 
and controls 
C1 30 22 35 
C2 21 16 30 
C3 31 30 28 
Total 82 68 93 
The theme of employee training was a concept emphasized by SCM executives 
relative to the end-to-end strategy of compliant shipping of DMDs.  SCM executives 
reported that employees must train on standard operating procedures and work 
instructions to ensure compliant storage and shipping of temperature-sensitive DMD tests 
and controls.  Educated SCM practitioners have a working knowledge of the regulatory 
requirements needed to ship temperature-sensitive products globally from a storage and 
transportation perspective (Lis et al., 2009).  End users require training on how to manage 
temperature-sensitive products (Maltha et al., 2013).  SCM executives also noted that 
they monitor the effectiveness of training for their employees through audits. 
The auditing of business processes was another theme mentioned by SCM 
executives to ensure compliant shipping.  Reddy et al. (2012) asserted that SCM 
practitioners find it increasingly important to use proper storage, handling, and 
distribution of temperature-sensitive products.  SCM executives remarked that both 
internal and external audits are effective means of confirming and ensuring proper 
96 
 
storage conditions, warehouse temperature mapping, CCSSs validations, compliant 
shipping, and training effectiveness. 
The final theme identified in this end-to-end strategy was SCM executives’ 
assertion that the monitoring of DMD tests and controls during shipping provides 
meaningful insights into compliance.  SCM executives can gain proactive insight into 
compliance by using temperature-monitoring devices.  Attached temperature control 
monitoring tags in a CCSS could reveal temperature excursions during transit (Maltha et 
al., 2013).  SCM executives noted that they receive reactive insight into compliance from 
their customer and technical services.  Customer and technical service representatives 
typically generate reactive reports in response to customer complaints and 
announcements of patient harm.  SCM executives affirmed that it is their responsibility to 
ensure compliant shipping of DMD tests and controls to prevent harm.  Agents for the 
FDA recorded 659 instances of medical device recalls in 2006, which contributed to 
116,086 injuries and 2,830 deaths (FDA, 2006; Sullivan, 2014). 
These themes indicated that SCM executives take a methodical approach to 
ensure compliant shipping.  However, data supported the proposition that organizational 
and educational requirements for SCM executives in the medical device industry may be 
inconsistent, which leads to the use of nonvalidated or poorly validated CCSSs.  Some 
SCM executives acknowledged that they have no formal training in CCM and that 
training typically takes place on the job or through attending conferences that include 
CCM as an agenda topic.  The inconsistent education of SCM executives in CCM 
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supports the conceptual framework used to develop the propositions that guided the 
study. 
One of the propositions mentioned in the SCA model is education and 
communication.  Leaders commonly use education and communication to persuade 
employees to accept organizational change (Kotter & Schlesinger, 1979).  The education 
and communication proposition is time-consuming to implement because leaders must 
engage most employees throughout the organization (Kotter & Schlesinger, 1979).  
Therefore, leaders seeking sustainable change must select strategies that diminish the 
resistance to change, which is inherent in people who do not want internal or external 
forces disrupting the status quo (Kotter & Schlesinger, 1979). 
End-to-End Strategy 3: Cold Chain Management Best Practices 
The third end-to-end strategy of the study linked the concept of CCM best 
practices to the proper storage and shipping of temperature-sensitive DMD tests and 
controls.  Three themes emerged from my data analysis, as shown in Table 8.  The 
emerging themes were (a) regulatory requirements, (b) product storage and shipping 
conditions, and (c) temperature excursion, as shown in the final cognitive map (see 
Appendix L). 
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Table 8 
Themes Relating to the End-to-End Strategy of CCM Best Practices 
Case Regulatory requirements 
Product storage and 
shipping conditions 
Temperature excursion 
C1 23 31 28 
C2 28 27 16 
C3 24 35 22 
Total 75 93 66 
The theme for complying with regulatory requirements was a concept emphasized 
by SCM executives.  According to the three SCM executives in this study, regulatory 
compliance in the area of CCM helps ensure DMD tests and controls function properly.  
SCM executives use a quality management system to align business practices with 
regulatory requirements.  The FDA (2006) regulates quality system adherence and good 
manufacturing practices.  FDA regulations require medical device manufacturers to 
document their storage and shipping requirements. 
SCM executives also emphasized the theme that linked proper product storage 
and shipping conditions to patient safety.  SCM executives determine proper product 
storage and shipping by referencing product labeling.  CCM is a controlled methodology 
for the proper storage and distribution of temperature-sensitive products (Reddy et al., 
2012). 
The final theme referenced by SCM executives was to avoid temperature 
excursion when shipping DMD tests and controls.  SCM executives noted that 
temperature excursion from improper storage and handling could result in DMD errors.  
SCM executives reported two types of errors: false negative and false positive.  
According to SCM executives, both types of error could cause patient harm.  Proper 
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CCM can prevent some medical errors by protecting proteins, antigens, and assays used 
in DMD tests and controls from temperature excursions (O’Connell et al., 2012; Smit et 
al., 2013). 
These themes revealed that SCM executives take a systematic approach to ensure 
proper CCM.  However, data supported the proposition that SCM executives in the 
medical device industry have different levels of competency regarding the distribution 
requirements for DMD tests and controls from a regulatory and stability perspective, 
which may contribute to inconsistent industry standards and health risks to patients.  
Some SCM executives remarked that the FDA does not provide specific guidance 
regarding CCM.  SCM executives had different levels of competency in regulatory 
requirements, which supports the conceptual framework used to develop the propositions 
that guided the study. 
Regulatory complexity and change require SCM executives to make 
organizational changes.  Leaders can use the SCA model to manage major issues based 
on the internal and external forces that disrupt the status quo of people in an organization 
(Kotter & Schlesinger, 1979).  Therefore, SCM executives who use the SCA model can 
improve business strategies in their respective organization. 
Applications to Professional Practice 
Compliant shipping of temperature-sensitive DMD tests and controls could 
mitigate temperature excursion and the associated diagnostic errors that lead to patient 
harm.  The in-depth exploration into SCM at the executive level generated valuable 
insights into validating CCSSs, compliant shipping of DMDs, and CCM best practices.  
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The insights gained from interviewing SCM executives who work in the medical device 
industry was pivotal to developing end-to-end strategies for shipping temperature-
sensitive DMD tests and controls. 
SCM executives responsible for shipping temperature-sensitive DMD tests and 
controls rely on the end-to-end strategy associated with shipping validations to ensure 
product efficacy.  SCM executives commission and collaborate with packaging 
manufacturers and packaging laboratories to develop and test shipping validations.  SCM 
executives ensure shipping validations are representative of the entire supply chain by 
confirming all external temperatures from the point of manufacturing to the end user.  
Therefore, validation protocols must define the testing parameters for developing 
validated CCSSs.  Validation protocols can include transit times, internal product 
temperature, external hot and cold temperature ranges, and various modes of 
transportation as part of the testing parameters for developing CCSSs. 
SCM executives emphasized compliance as an end-to-end strategy for ensuring 
the efficacy of temperature-sensitive DMD tests and controls.  SCM executives working 
in the medical device industry use quality management systems, such as ISO 13485:2016 
to ensure compliant shipping of temperature-sensitive DMD tests and controls.  More 
specifically, quality management systems provide the framework for managing business 
processes and employee training.  SCM executives use internal and external audits to 
ensure employee compliance with standard operating procedures and work instructions.  
SCM executives use audit findings to close gaps in the quality management system as it 
relates to people, processes, and systems.  SCM executives also use quality management 
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systems to help ensure compliant shipping of temperature-sensitive DMD tests and 
controls to end users. 
SCM executives reference CCM best practices as an end-to-end strategy for 
ensuring regulatory compliance of DMD tests and controls during storage and shipping.  
SCM executives achieve regulatory compliance when CCM activities adhere to the 
product labeling regarding storage and shipping.  SCM executives use active and passive 
validated CCSSs to prevent temperature excursions, which helps ensure product efficacy 
at the point of care.  Proper CCM can prevent some medical errors by protecting proteins, 
antigens, and assays used in DMD tests and controls from temperature excursions 
(O’Connell et al., 2012; Smit et al., 2013).  The prevention of medical errors may 
improve patient safety. 
Implications for Social Change 
Clinicians using defective DMDs contribute to medical errors, one of the leading 
causes of injury and death around the world, which cost the U.S. health care system 
approximately $17.1 billion in 2008 (Van Den Bos et al., 2011).  Consequently, the 
implications for positive social change as it relates to this study begins with SCM 
executives adopting CCM strategies and utilizing innovative CCSSs designed to mitigate 
temperature excursions for DMD tests and controls.  A decline in medical device failures 
could correlate to a reduction in FDA recalls, liability claims, and legal proceedings 
within the medical device industry. 
The end-to-end strategies associated with validating CCSSs, compliant shipping 
of DMDs, and CCM best practices could help SCM executives drive sustainable change 
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within the medical device industry.  The identification and adoption of CCM strategies by 
SCM executives may prevent a medical device failure that results in FDA recalls.  A 
reduction in FDA recalls and the resulting litigations could positively influence medical 
device executives to invest in new business opportunities. 
The funding of new business opportunities could increase manufacturing capacity 
and support R&D advancements in medical device technology.  Such a shift could 
eventually create new jobs, reduce health care costs, and bring to market new diagnostic 
technologies that could save additional lives or improve a patient’s well-being.  
Therefore, CCM strategies could increase profitability, patient safety, and lead to 
technological advancements in DMDs from a social change perspective. 
Recommendations for Action 
The recommendation for action is for SCM executives to initiate a comprehensive 
review of their CCM practices by focusing on the end-to-end strategies associated with 
validating CCSSs, compliant shipping of DMDs, and CCM best practices.  SCM 
executives should obtain the master data for all DMD tests and controls that require 
CCM.  SCM executives should then ensure master data matches product labeling.  
Finally, SCM executives should select validated CCSSs based on master data, transits 
time, and the final destination. 
The lack of validated CCSSs emphasizes a need for SCM executives to form a 
partnership with a third-party validation firm for the development of compliant CCSSs.  
SCM executives should also ensure a quality management system support CCSSs 
through standard operating procedures, and internal and external audits.  Finally, SCM 
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executives should create an adequate feedback loop for customer complaints and patient 
harm to drive continuous improvement from a CCM perspective. 
The findings from this study are relevant to SCM executives and leaders seeking 
to improve CCM practices within the medical device industry.  Participants of this study 
may seek to align global CCM practices, develop cold chain centers of excellence, and 
form strategic partnerships with packaging manufacturers and packaging laboratories.  
Third-party validation firms may use conferences or literature to share the results of this 
study with SCM leaders seeking to improve CCM practices in the medical device 
industry. 
Future researchers may use the results of this study as a means to expand on the 
CCM body of knowledge.  I will publish this doctoral study with ProQuest and further 
disseminate the study findings in peer-reviewed journals.  I will also disseminate my 
findings to stakeholders in the medical device industry by way of seminars and 
conferences. 
Recommendations for Further Research 
The purpose of the study was to explore medical device executives’ strategies for 
shipping temperature-sensitive DMD tests and controls.  The results of the study revealed 
that validating CCSSs, compliant shipping of DMDs, and CCM best practices are 
effective strategies for SCM executives to drive compliant CCM of temperature-sensitive 
products.  To advance the research associated with this study, I recommend further 
research using qualitative and quantitative designs to explore the limitations and 
delimitations acknowledged in this study. 
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Researchers use phenomenological research to survey data and draw conclusions 
from the lived experiences of participants (Wolgemuth et al., 2014).  I recommend a 
qualitative phenomenological study to understand the types of risks associated with 
improper storage and distribution of temperature-sensitive DMD tests and controls.  
Further research may provide new insights to improve patient safety after a DMD 
malfunction. 
Yilmaz (2013) defined quantitative research as a research method used to gain 
understanding into a phenomenon through statistical analysis.  I also recommend a 
quantitative study to analyze the FDA reason codes for medical device failures.  Further 
research could narrow the scope of medical device failures to those caused by 
temperature excursions.  SCM executives and third-party validation firms can use these 
new finding to drive innovation in CCSSs. 
Reflections 
My objective for conducting a doctoral study through Walden University was to 
advance my professional and academic expertise and to distinguish myself as a scholar-
practitioner in SCM.  To that end, I conducted a qualitative multiple case study design 
using cognitive mapping to explain what strategies SCM executives deploy in the 
selection, management, and utilization of CCSSs in the medical device industry.  The 
engagement with SCM executives was rewarding.  However, the real-time data collection 
and entry into Decision Explorer was burdensome.  The burden was prolonged case study 
interviews requiring propositions to achieve a conversational tone and the pace of my 
conversation not being conducive to real-time data entry into Decision Explorer.  
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Consequently, I had to transcribe recorded interviews and perform member checking to 
complete each cognitive map. 
The rendering of unbiased conclusions was paramount as a scholar-practitioner 
reporting on strategies used by SCM executives working in the medical device industry.  
My direct knowledge and experience in CCM within the medical device industry created 
a risk for the introduction of bias.  To prevent personal bias, I developed interview 
protocols, avoided leading questions, and rendered conclusions based on transcribed data 
that incorporated member checking. 
Conclusion 
Clinicians use DMDs to diagnose various diseases such as cardiovascular, 
respiratory, toxicology, autoimmune, and infectious diseases in patients.  The use of 
defective DMDs contributes to medical errors, which is one of the leading causes of 
injury and death throughout the world.  Consequently, medical errors cost the U.S. health 
care system approximately $17.1 billion in 2008 (Van Den Bos et al., 2011).  Proper 
CCM can prevent some medical errors by protecting proteins, antigens, and assays used 
in DMD tests and controls from temperature excursions (O’Connell et al., 2012; Smit et 
al., 2013).  The lack of proper CCM should be of concern to SCM executives responsible 
for shipping temperature-sensitive DMD tests and controls. 
The purpose of this qualitative multiple case study was to identify successful 
strategies used by SCM executives to ship temperature-sensitive DMD tests and controls.  
The exhaustive exploration into SCM executives’ understanding of CCM within the 
medical device industry made it possible to pinpoint end-to-end strategies to help 
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improve patient safety.  The results of this study yielded strategies SCM executives and 
stakeholders can use for (a) validating CCSSs, (b) achieving compliant shipping of DMD 
tests and controls, and (c) implementing CCM best practices in the medical device 
industry.  SCM executives who adopt the three end-to-end strategies identified in this 
study could develop a comprehensive strategy that improves patient safety within the 
medical device industry. 
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Appendix A: Invitation Letter 
Dear Supply Chain Executive, 
  
As a supply chain executive in the medical device industry, you are invited to participate 
in a doctoral study regarding the distribution of temperature-sensitive diagnostic medical 
device tests and controls. 
 
The purpose of this qualitative multiple case study design is to explore medical device 
executives’ strategies for shipping temperature-sensitive diagnostic medical device tests 
and controls. 
 
If you agree to participate in this voluntary doctoral study, I will send you a consent form 
and the eligibility form.  These two documents further explain the study, interview 
duration, privacy protections, and consent. 
 
Please note that your participation in this doctoral study is voluntary and that all 
information obtained up to and including your identity will remain strictly confidential. 
I appreciate the consideration you will give toward your participation in this doctoral 
study. 
 
Sincerely, 
 
 
 
Eric C. Guynes 
Walden University School of Management and Technology  
DBA Candidate, Specialization: Global Supply Chain Management 
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Appendix B: Participatory Eligibility Form 
Dear Supply Chain Executive, 
 
The intent of this eligibility form is to ensure that all participants meet the minimum 
qualification of a supply chain executive as defined in this study.  The scrutiny of each 
participant helps protect the integrity and outcomes of this doctoral study. 
 
Please check the box for each statement that applies 
 
 I have worked in the medical device industry. 
 I have 5 or more years of cold chain management experience. 
 I have national or global supply chain management responsibilities. 
 I can influence cold chain management strategies within my organization. 
 
I have read the above statements, and I certify that each statement checked is true. 
 
 
For Internal Use Only: 
 
Participant’s Printed Name: 
 
 
Participant’s Employer: 
 
 
Participant’s Job Title: 
 
 
Date: 
 
 
 
 
 
Case Number: 
 
 
Geographical Responsibility: 
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Appendix C: Permission for Reprint 
2/112016 Walden University Mail- Permission Request 
1/3 
 
 
 
 
 
 
Permission Request 
 
 
 
Eric Guynes 
 
PermissionsUK <Permissions@sagepub.co.uk> Tue, Nov 24, 2015 at 2:16PM 
Dear Eric C. Guynes, 
Thank you for your request to reuse "Figure 5.1 A typology of case study" from The Anatomy of the Case 
Study. I am pleased to report we can grant your request without a fee as part of your thesis or dissertation. 
 
 
 
 
Please accept this email as permission for your request as detailed below.   Permission is granted for the 
life of the edition on a non-exclusive basis,in the English language,throughout the world in all formats 
provided full citation is made to the original SAGE publication. 
 
 
 
As a courtesy, we ask that you contact the author to let them know the content will be republished. Please 
note this approval excludes any content which requires additional permission from a separate copyright 
holder.  If the SAGE material includes anything not'© the Author' or'© SAGE', please contact the rights 
holder for permission to reuse those items. 
 
 
 
We wish you the best of luck with your project! 
Best Wishes, 
Craig Myles 
 
on behalf of SAGE ltd.Permissions Team 
 
 
 
 
SAGE Publications Ltd 
 
1Oliver's Yard, 55 City Road 
 
London, ECYl lSP 
 
UK 
 
www.sagepub.co.uk 
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Appendix D: Receipt of Purchase for Decision Explorer and Authorization of Use 
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Appendix E: Confidentiality Agreement 
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Appendix F: Online Interview Protocol 
What I will do What I will say 
Introduce the interview and set 
the stage 
1. Welcome the participant. 
2. Discuss confidentiality for the participant and their 
employer. 
3. Discuss consent and voluntary withdraw. 
4. Confirm permission to voice-record. 
5. Explain how I will use Decision Explorer in real-time to 
construct three cognitive maps. 
6. Explain that voice recording are to refine cognitive 
maps. 
7. Explain interview rules to ensure participants understand 
(a) the structured set of open-ended interview questions; 
(b) the need for follow-up questions based on 
propositions; and (c) that answer deviations are 
acceptable, but must be limited. 
8. Explain the use of a parking lot during the construct of 
real-time maps. 
9. Explain how real-time member checking enhances the 
reliability and validity of each cognitive map. 
10. Remind the participant that the interview will take 2 
hours and that they can request a short break. 
11. Confirm participant do not have any questions and or 
concerns. 
12. Introduce the study and start the interview. 
I will perform the following when 
interviewing (a) watch for 
nonverbal cues; (b) paraphrase as 
needed; (c) enter each interview 
response into Decision Explorer 
in real-time; (d) member check 
each interview response captured 
in Decision Explorer in real-
time;(e) ask follow-up questions 
based on propositions and then 
repeat (c) and (d) above. 
1. How do you evaluate if CCSSs can protect against 
extreme heat within the medical device industry? 
2. How do you evaluate if CCSSs can protect against 
extreme cold within the medical device industry? 
3. What types of CCSSs do you deploy in your supply 
chain? 
4. How do validations prevent temperature excursions for 
your diagnostic medical device (DMD) tests and 
controls? 
5. How do you innovate cold chain shipping within your 
organization over the next 5 years?  
6. How did you learn about cold chain management (CCM) 
in relation to the medical device industry? 
7. How do you identify CCM deficiencies within your 
organization? 
8. How does education influence your selection of cold 
chain shipping solution for DMD tests and controls? 
9. How do you increase CCM awareness within your 
organization? 
10. How will you ensure that your organization has ongoing 
expertise in CCM? 
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11. How do you determine if DMD tests and controls are 
temperature controlled? 
12. How does the FDA influence the distribution of DMD 
tests and controls? 
13. How do you ensure internal CCM compliance for 
the DMD tests and controls shipped?  
14. How does temperature excursion on DMD tests and 
controls affect patient safety? 
15. Why do you control the temperature stability for 
DMD tests and controls? 
16. Futuristically: How will governmental regulations 
influence the CCM of DMD tests and controls over the 
next 5 years? 
Wrap up interview thanking 
participant  
I will verbally (a) thank the participant; (b) briefly discuss 
next steps; and (c) confirm the participant does not have any 
questions and or concerns. 
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Appendix G: Interview Questions 
1. What types of CCSSs do you deploy in your supply chain? 
2. What methods do you use to evaluate CCSSs intended to protect against extreme 
temperature ranges? 
3. How do you monitor the effectiveness of CCSSs used to ship diagnostic medical 
device (DMD) tests and controls? 
4. How do you validate CCSSs used in your supply chain? 
5. What cold chain shipping innovations are you considering for your organization? 
6. How did you learn about cold chain management (CCM) as it pertains to the 
medical device industry? 
7. How do you identify CCM deficiencies within your organization? 
8. How does education influence your selection of CCSSs for DMD tests and 
controls? 
9. How do you increase CCM awareness within your organization? 
10. How do you develop CCM expertise within your organization? 
11. How do you determine the need for temperature controlled shipping? 
12. How does the FDA influence the shipping of DMD tests and controls? 
13. How do you ensure internal CCM compliance when shipping? 
14. How does temperature excursion on DMD tests and controls affect patient safety? 
15. Why do you ensure temperature compliant shipping for DMD tests and controls? 
16. How do governmental regulations influence the CCM of DMD tests and controls? 
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Appendix H: Coding of Propositions to Interview Questions in Decision Explorer 
Propositions Interview Questions 
P1. Cold chain shipping 
solutions (CCSS) used in 
the medical device 
industry are validated, 
nonvalidated, or poorly 
validated, which may 
indicate a lack of 
standardization and 
inconsistent distribution 
strategies. 
Q1. What types of CCSSs do you deploy in your 
supply chain? 
Q2. What methods do you use to evaluate CCSSs 
intended to protect against extreme temperature 
ranges? 
Q3. How do you monitor the effectiveness of CCSSs 
used to ship diagnostic medical device (DMD) 
tests and controls? 
Q4. How do you validate CCSSs used in your supply 
chain? 
Q5. What cold chain shipping innovations are you 
considering for your organization? 
 
P2. Organizational and 
educational requirements 
for supply chain 
management (SCM) 
executives in the medical 
device industry may be 
inconsistent, which leads 
to the use of nonvalidated 
or poorly validated 
CCSSs. 
 
Q6. How did you learn about cold chain management 
(CCM) as it pertains to the medical device 
industry? 
Q7. How do you identify CCM deficiencies within 
your organization? 
Q8. How does education influence your selection of 
CCSSs for DMD tests and controls? 
Q9. How do you increase CCM awareness within 
your organization? 
Q10. How do you develop CCM expertise within your 
organization? 
 
P3. SCM executives in the 
medical device industry 
have varying competency 
regarding the distribution 
requirements for DMD 
tests and controls from a 
regulatory and stability 
perspective, which may 
contribute to inconsistent 
industry standards and 
health risks to patients 
Q11. How do you determine the need for temperature 
controlled shipping? 
Q12. How does the FDA influence the shipping of 
DMD tests and controls? 
Q13. How do you ensure internal CCM compliance 
when shipping? 
Q14. How does temperature excursion on DMD tests 
and controls affect patient safety? 
Q15. Why do you ensure temperature compliant 
shipping for DMD tests and controls? 
Q16. How do governmental regulations influence the 
CCM of DMD tests and controls? 
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Appendix I: Coding of Case Studies in Decision Explorer 
 
Participant and Employer 
 
Geographical Responsibility 
Interview Questions 
and Answers 
Case 1 New Jersey 0001 – 0999 
Case 2 Ireland 1000 – 1999 
Case 3 San Diego 2000 – 2999 
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Appendix J: Final Cognitive Map C123 P1 
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Appendix K: Final Cognitive Map C123 P2 
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Appendix L: Final Cognitive Map C123 P3 
 
